Professor Andrew Carr

Mallon PWG; Cooper DA; Carr A, 2004, 'Chapter 33 Toxicities of Antiretroviral Therapy', in AIDS and Other Manifestations of HIV Infection, Elsevier, pp. 867 - 882, http://dx.doi.org/10.1016/b978-012764051-8/50035-4

Mallon PWG; Cooper DA; Carr A, 2004, 'Toxicities of Antiretroviral Therapy', in AIDS and Other Manifestations of HIV Infection, pp. 867 - 882, http://dx.doi.org/10.1016/B978-012764051-8/50035-4

Carr AD; Cooper DA, 2000, 'Primary HIV infection', in AIDS Pathogenesis, edn. Original, Kluwer Academic Publishers, Netherlands, pp. 19 - 40

Carr AD; Cooper DA, 1999, 'Primary HIV infection', in The Medical Management of AIDS, edn. Original, W B Saunders Company, Pennsylvania, pp. 67 - 78

Aung HL; Siefried KJ; Gates TM; Brew BJ; Mao L; Carr A; Cysique LA, 2023, 'Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not', eClinicalMedicine, vol. 56, pp. 101792 - 101792, http://dx.doi.org/10.1016/j.eclinm.2022.101792

Dharan NJ; Jin F; Vaccher S; Bavinton B; Yeung B; Guy R; Carr A; Zablotska I; Amin J; Read P; Templeton DJ; Oii C; Martin SJ; Ryder N; Smith DE; McNulty A; Brown K; Price K; Holden J; Grulich AE, 2022, 'Characteristics of HIV Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciac660

Hernández Cordero AI; Yang CX; Yang J; Li X; Horvath S; Shaipanich T; MacIsaac J; Lin D; McEwen L; Kobor MS; Guillemi S; Harris M; Lam W; Lam S; Obeidat M; Novak RM; Hudson F; Klinker H; Dharan N; Montaner J; Man SFP; Kunisaki K; Sin DD; Leung JM; Baker JV; Duprez D; Carr A; Hoy J; Dolan M; Telenti A; Grady C; Matthews G; Rockstroh J; Belloso WH; Kagan JM; Wright E; Brew B; Price RW; Robertson K; Cysique L; Connett JE; Niewoehner DE; Endpoint Review Committee ; Lifson A; Davey RT; Gatell JM; Pedersen C; Prineas R; Worley J, 2022, 'The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study', eBioMedicine, vol. 83, http://dx.doi.org/10.1016/j.ebiom.2022.104206

Loprete J; Katelaris CH; Evans L; Kane A; McMullan B; Wainstein B; Wong M; Post J; Suan D; Swaminathan S; Richardson R; Rogers J; Torda A; Campbell DE; Kelleher AD; Law M; Carr A; Tong WWY, 2022, 'Standardized testing and written communication improve patient understanding of beta-lactam allergy testing outcomes: A multicenter, prospective study', Journal of Allergy and Clinical Immunology: Global, vol. 1, pp. 99 - 105, http://dx.doi.org/10.1016/j.jacig.2022.05.003

Neesgaard B; Greenberg L; Miró JM; Grabmeier-Pfistershammer K; Wandeler G; Smith C; De Wit S; Wit F; Pelchen-Matthews A; Mussini C; Castagna A; Pradier C; d'Arminio Monforte A; Vehreschild JJ; Sönnerborg A; Anne AV; Carr A; Bansi-Matharu L; Lundgren JD; Garges H; Rogatto F; Zangerle R; Günthard HF; Rasmussen LD; Necsoi C; van der Valk M; Menozzi M; Muccini C; Peters L; Mocroft A; Ryom L, 2022, 'Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium', The Lancet HIV, vol. 9, pp. e474 - e485, http://dx.doi.org/10.1016/S2352-3018(22)00094-7

Penglase R; Englert H; Tymms K; Carr A; Ma D; Milliken S; Moore J, 2022, 'Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning—do we need 200 mg/kg cyclophosphamide?', Bone Marrow Transplantation, vol. 57, pp. 1207 - 1209, http://dx.doi.org/10.1038/s41409-022-01696-5

Poynten IM; Jin F; Roberts JM; Templeton DJ; Law C; Cornall AM; Molano M; Machalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2022, 'The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men (vol 72, pg 853, 2021)', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciac150

Chan C; Fraser D; Vaccher S; Yeung B; Jin F; Amin J; Dharan NJ; Carr A; Ooi C; Vaughan M; Holden J; Power C; Grulich AE; Bavinton BR, 2021, 'Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: Results from the MI-EPIC clinical trial', Sexual Health, vol. 18, pp. 453 - 459, http://dx.doi.org/10.1071/SH21096

Ezard N; Clifford B; Dunlop A; Bruno R; Carr A; Liu Z; Siefried KJ; Lintzeris N, 2021, 'Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: A phase-2 dose-escalation study', BMJ Open, vol. 11, pp. e044696, http://dx.doi.org/10.1136/bmjopen-2020-044696

Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R, 2021, 'Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study', The Lancet HIV, vol. 8, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(21)00074-6

McManus H; Callander D; Asselin J; McMahon J; Hoy JF; Templeton DJ; Fairley CK; Donovan B; Pedrana AE; Keen P; Wilson DP; Elliott J; Kaldor J; Liaw ST; Petoumenos K; Holt M; Hellard ME; Grulich AE; Carr A; Stoove MA; Guy RJ, 2021, 'A New Method for Estimating the Incidence of Infectious Diseases', American Journal of Epidemiology, vol. 190, pp. 1386 - 1395, http://dx.doi.org/10.1093/aje/kwab014

Poynten IM; Jin F; Roberts JM; Templeton DJ; Law C; Cornall AM; Molano M; MacHalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2021, 'The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men', Clinical Infectious Diseases, vol. 72, pp. 853 - 861, http://dx.doi.org/10.1093/cid/ciaa166

van Santen DK; Asselin J; Haber NA; Traeger MW; Callander D; Donovan B; El-Hayek C; McMahon JH; Petoumenos K; McManus H; Hoy JF; Hellard M; Guy R; Stoové M; Carr A; Elliot J; Templeton DJ; Liaw T; Wilson DP, 2021, 'Improvements in transition times through the HIV cascade of care among gay and bisexual men with a new HIV diagnosis in New South Wales and Victoria, Australia (2012–19): a longitudinal cohort study', The Lancet HIV, vol. 8, pp. e623 - e632, http://dx.doi.org/10.1016/S2352-3018(21)00155-7

Calon M; Menon K; Carr A; Henry RG; Rae CD; Brew BJ; Cysique LA, 2020, 'Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV', Journal of Acquired Immune Deficiency Syndromes, vol. 84, pp. 543 - 551, http://dx.doi.org/10.1097/QAI.0000000000002390

Carr A; Grund B; Schwartz AV; Avihingsanon A; Badal-Faesen S; Bernadino JI; Estrada V; La Rosa A; Mallon PWG; Pujari S; White D; Wyman Engen N; Ensrud K; Hoy JF, 2020, 'The rate of bone loss slows after 1–2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy', HIV Medicine, vol. 21, pp. 64 - 70, http://dx.doi.org/10.1111/hiv.12796

Goddard SL; Templeton DJ; Petoumenos K; Jin F; Hillman RJ; Law C; Roberts JM; Fairley CK; Garland SM; Grulich AE; Poynten IM; Farnsworth A; Biro C; Richards A; Thurloe J; Ekman D; McDonald R; Adams M; Tabrizi S; Phillips S; Luque MM; Comben S; McCaffery K; Howard K; Kelly P; Seeds D; Carr A; Feeney L; Gluyas R; Prestage G; Law M; Acraman B; McGrath P; Mellor R; Pezzopane P; Varma R; Langton-Lockton J; Tong W, 2020, 'Prevalence and association of perianal and intra-anal warts with composite high-grade squamous intraepithelial lesions among gay and bisexual men: Baseline data from the study of the prevention of anal cancer', AIDS Patient Care and STDs, vol. 34, pp. 436 - 443, http://dx.doi.org/10.1089/apc.2020.0067

Carr A; Kerr SJ; Richardson R; Ebeling P; Pocock N; Rojas J; Martinez E; Hoy J, 2019, 'Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label Study', Journal of Bone and Mineral Research, vol. 34, pp. 2192 - 2197, http://dx.doi.org/10.1002/jbmr.3834

Carr A; Richardson R; Liu Z, 2019, 'Success and failure of initial antiretroviral therapy in adults: An updated systematic review', AIDS, vol. 33, pp. 443 - 453, http://dx.doi.org/10.1097/QAD.0000000000002077

Goddard SL; Templeton DJ; Petoumenos K; Jin F; Hillman RJ; Law C; Roberts JM; Fairley CK; Garland SM; Grulich AE; Poynten IM, 2019, 'Association of anal symptoms with anal high grade squamous intraepithelial lesions (HSIL) among men who have sex with men: Baseline data from the study of the prevention of anal cancer (SPANC)', Cancer Epidemiology, vol. 58, pp. 12 - 16, http://dx.doi.org/10.1016/j.canep.2018.10.009

Hoy JF; Richardson R; Ebeling PR; Rojas J; Pocock N; Kerr SJ; Martinez E; Carr A, 2018, 'Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV', AIDS, vol. 32, pp. 1967 - 1975, http://dx.doi.org/10.1097/QAD.0000000000001911

McMahon CN; Petoumenos K; Hesse K; Carr A; Cooper DA; Samaras K, 2018, 'High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years', AIDS, vol. 32, pp. 451 - 459, http://dx.doi.org/10.1097/QAD.0000000000001709

McMahon CN; Petoumenos K; Hesse K; Carr A; Cooper DA; Samaras K, 2018, 'High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years.', AIDS, vol. 32, pp. 451 - 459, http://dx.doi.org/10.1097/QAD.0000000000001709

Orkin C; Llibre JM; Gallien S; Antinori A; Behrens GMN; Carr A, 2018, 'Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence', HIV Medicine, vol. 19, pp. 18 - 32, http://dx.doi.org/10.1111/hiv.12534

Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; De Wit J; Carr A, 2018, 'Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy', AIDS, vol. 32, pp. 35 - 48, http://dx.doi.org/10.1097/QAD.0000000000001685

Hey-Nguyen WJ; Xu Y; Pearson CF; Bailey M; Suzuki K; Tantau R; Obeid S; Milner B; Field A; Carr A; Bloch M; Cooper DA; Kelleher AD; Zaunders JJ; Koelsch KK, 2017, 'Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes during Antiretroviral Therapy', AIDS Research and Human Retroviruses, vol. 33, pp. 648 - 657, http://dx.doi.org/10.1089/aid.2016.0171

Hoy JF; Grund B; Roediger M; Schwartz AV; Shepherd J; Avihingsanon A; Badal-Faesen S; de Wit S; Jacoby S; La Rosa A; Pujari S; Schechter M; White D; Engen NW; Ensrud K; Aagaard PD; Carr A, 2017, 'Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial', Journal of Bone and Mineral Research, vol. 32, pp. 1945 - 1955, http://dx.doi.org/10.1002/jbmr.3183

Jin F; Roberts JM; Grulich AE; Poynten IM; MacHalek DA; Cornall A; Phillips S; Ekman D; McDonald RL; Hillman RJ; Templeton DJ; Farnsworth A; Garland SM; Fairley CK; Tabrizi SN; Law C; Biro C; Richards A; Thurloe J; Adams M; McCaffery K; Howard K; Kelly P; Seeds D; Garcia M; Carr A; Feeney L; Gluyas R; Prestage G; Petoumenos K; Law M; Acraman B; McGrath P; Mellor R; Pezzopane P, 2017, 'The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men', AIDS, vol. 31, pp. 1303 - 1311, http://dx.doi.org/10.1097/QAD.0000000000001462

McAllister JW; Towns JM; McNulty A; Pierce AB; Foster R; Richardson R; Carr A, 2017, 'Dolutegravir with tenofovir disoproxil fumarate-emtricitabine as HIV postexposure prophylaxis in gay and bisexual men', AIDS, vol. 31, pp. 1291 - 1295, http://dx.doi.org/10.1097/QAD.0000000000001447

Poynten IM; Tabrizi SN; Jin F; Templeton DJ; Machalek DA; Cornall A; Phillips S; Fairley CK; Garland SM; Law C; Carr A; Hillman RJ; Grulich AE, 2017, 'Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men', Papillomavirus Research, vol. 3, pp. 80 - 84, http://dx.doi.org/10.1016/j.pvr.2017.02.003

Puhr R; Petoumenos K; Youds D; Law MG; Templeton DJ; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Rankin A; Baker D; O'Connor CC; Thackeray O; Jackson E; McCallum K; Ryder N; Sweeney G; Cooper D; Carr A; Macrae K; Hesse K; Finlayson R; Gupta S; Langton-Lockton J; Shakeshaft J; Brown K; Idle S; Arvela N; Varma R; Lu H; Couldwell D; Eswarappa S; Smith DE; Furner V; Cabrera G; Fernando S; Cogle A; Lawrence C; Mulhall B; Boyd M; Law M; Huang R; Han A; Gunathilake M; Payne R; O'Sullivan M; Croydon A; Russell D; Cashman C; Roberts C; Sowden D; Taing K; Marshall P; Orth D; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Allen A; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K, 2017, 'The impact of changes in HIV management guidelines on time to treatment initiation in Australia', HIV Medicine, vol. 18, pp. 701 - 703, http://dx.doi.org/10.1111/hiv.12504

Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; De Wit J; Carr A, 2017, 'Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0174613

Templeton DJ; Roberts JM; Poynten IM; Law C; Hillman RJ; Farnsworth A; Fairley CK; Tabrizi SN; Garland SM; Grulich AE; Jin F; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley K; Feeney L; Fraissard E; Howard K; Law M; MacHalek D; McCaffery K; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2017, 'Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: Baseline findings from the Study of the Prevention of Anal Cancer (SPANC)', European Journal of Cancer Prevention, vol. 26, pp. 212 - 216, http://dx.doi.org/10.1097/CEJ.0000000000000321

Callander D; Stoové M; Carr A; Hoy JF; Petoumenos K; Hellard M; Elliot J; Templeton DJ; Liaw S; Wilson DP; Grulich A; Cooper DA; Pedrana A; Donovan B; McMahon J; Prestage G; Holt M; Fairley CK; McKellar-Stewart N; Ruth S; Asselin J; Keen P; Cooper C; Allan B; Kaldor JM; Guy R, 2016, 'A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: The Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol', BMC Infectious Diseases, vol. 16, pp. 752, http://dx.doi.org/10.1186/s12879-016-2073-2

Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2016, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, vol. 22, pp. 56 - 65, http://dx.doi.org/10.1007/s13365-015-0368-5

Ezard N; Dunlop A; Clifford B; Bruno R; Carr A; Bissaker A; Lintzeris N, 2016, 'Study protocol: A dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence', BMC Psychiatry, vol. 16, http://dx.doi.org/10.1186/s12888-016-1141-x

Ezard N; Dunlop AJ; Clifford B; Bruno R; Carr A; Bissaker A; Lintzeris N, 2016, 'LISDEX I: DOSE-ESCALATING, PHASE-2 STUDY OF ORAL LISDEXAMFETAMINE IN ADULTS WITH METHAMPHETAMINE DEPENDENCE', DRUG AND ALCOHOL REVIEW, vol. 35, pp. 36 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hillman RJ; Gunathilake MPW; Jin F; Tong W; Field A; Carr A, 2016, 'Ability to detect high-grade squamous anal intraepithelial lesions at high resolution anoscopy improves over time', Sexual Health, vol. 13, pp. 177 - 181, http://dx.doi.org/10.1071/SH15170

Lee FJ; Marriott D; Bloch M; Richardson R; Mackenzie N; Carr A, 2016, 'Post-prandial lipid effects of raltegravir versus darunavir/ritonavir in HIV-1-infected adults commencing combination ART', Journal of Antimicrobial Chemotherapy, vol. 71, pp. 1127 - 1129, http://dx.doi.org/10.1093/jac/dkv436

Lee FJ; Monteiro P; Baker D; Bloch M; Roth N; Finlayson R; Moore R; Hoy J; Martinez E; Carr A, 2016, 'Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial', HIV Medicine, vol. 17, pp. 605 - 614, http://dx.doi.org/10.1111/hiv.12362

Machalek DA; Jin F; Poynten IM; Hillman RJ; Templeton DJ; Law C; Roberts JM; Tabrizi SN; Garland SM; Farnsworth A; Fairley CK; Grulich AE; Acraman B; Adams M; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Ekman D; Feeney L; Fraissard E; Howard K; Law M; McCaffery K; McDonald R; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2016, 'Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men', Papillomavirus Research, vol. 2, pp. 97 - 105, http://dx.doi.org/10.1016/j.pvr.2016.05.003

O'Dwyer EJ; Bhamra-Ariza P; Rao S; Emmanuel S; Carr A; Holloway CJ, 2016, 'Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome', Open Heart, vol. 3, http://dx.doi.org/10.1136/openhrt-2016-000511

Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers RL; Reiss P; van Sighem AI; Nelson M; Montaner JSG; Lane HC; Larder BA; Harrigan R; de Wit TR; Hamers R; Sigaloff K; Agan B; Marconi V; Wegner S; Sugiura W; Zazzi M; Kaiser R; Schuelter E; Streinu-Cercel A; Alvarez-Uria G; Gatell J; Lazzari E; Gazzard B; Pozniak A; Mandalia S; Webster D; Smith C; Ruiz L; Clotet B; Staszewski S; Torti C; Lane C; Metcalf J; Perez-Elias MJ; Vella S; Dettorre G; Carr A; Norris R; Hesse K; Vlahakis E; Barth R; Hoffmann C; Ene L; Dragovic G; Diaz R; Sucupira C; Sued O; Cesar C; Madero JS; Emery S; Cooper D; Baxter J; Monno L; Picchio G; deBethune MP; Khabo P; Ledwaba L, 2016, 'An update to the HIV-TRePS system: The development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype', Journal of Antimicrobial Chemotherapy, vol. 71, pp. 2928 - 2937, http://dx.doi.org/10.1093/jac/dkw217

Roberts JM; Jin F; Thurloe JK; Ekman D; Adams MK; McDonald RL; Biro C; Poynten IM; Grulich AE; Farnsworth A; Aarnsworth R; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley C; Farnsworth A; Feeney L; Garcia M; Garland S; Gluyas R; Hillman R; Howard K; Lawa F; Law C; Law M; Machalek D; McCaffery K; McGrath P; Mellor R; Pendlebury S; Petoumenos K; Pezzopane P; Phillips S; Mary Poynten I; Prestage G; Richards A; Seeds D; Segelov E; Tabrizi S; Templeton D; Tong W; Varma R, 2016, 'The value of a transformation zone component in anal cytology to detect HSIL', Cancer Cytopathology, vol. 124, pp. 596 - 601, http://dx.doi.org/10.1002/cncy.21730

Stellbrink HJ; Le Fevre E; Carr A; Saag MS; Mukwaya G; Nozza S; Valluri SR; Vourvahis M; Rinehart AR; McFadyen L; Fichtenbaum C; Clark A; Craig C; Fang AF; Heera J, 2016, 'Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment', AIDS, vol. 30, pp. 1229 - 1238, http://dx.doi.org/10.1097/QAD.0000000000001058

Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I; Carr A; Cheung C; Foster R; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; Murphy D; Ooi C; Pell C; Ryder N; De Wit J; Wright E, 2016, 'Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE', BMJ Open, vol. 6, http://dx.doi.org/10.1136/bmjopen-2016-012179

Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino J; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J, 2015, 'Prevalence of and risk factors for low bone mineral density in untreated HIV infection: A substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV Medicine, vol. 16, pp. 137 - 146, http://dx.doi.org/10.1111/hiv.12242

Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2015, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, vol. 22, pp. 56 - 65, http://dx.doi.org/10.1007/s13365-015-0368-5

Foster R; McAllister J; Read TR; Pierce AB; Richardson R; McNulty A; Carr A, 2015, 'Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex with Men', Clinical Infectious Diseases, vol. 61, pp. 1336 - 1341, http://dx.doi.org/10.1093/cid/civ511

Han N; Wright ST; O'Connor CC; Hoy J; Ponnampalavanar S; Grotowski M; Zhao HX; Kamarulzaman A; Ellis D; Bloch M; Franic T; Agrawal S; McCann L; Cunningham N; Vincent T; Allen D; Little JL; Smith D; Gray C; Baker D; Vale R; Templeton DJ; Dijanosic C; Jackson E; McCallum K; Taylor S; Cooper D; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Shakeshaft J; Brown K; McGrath C; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Watson J; Lawrence C; Mulhall B; Law M; Petoumenos K; McManus H; Bendall C; Boyd M; Kulatunga A; Knibbs P; Chuah J; Ngieng M; Dickson B; Russell D; Downing S; Sowden D; Broom J; Taing K; Johnston C; McGill K; Orth D; Youds D; Kelly M; Gibson A; Magon H; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Nicolson J; Lau H; Read T; Silvers J; Zeng W; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Skett J; Robinson J; Mean CV; Saphonn V; Vohith K; Zhang FJ; Li PCK; Lee MP; Kumarasamy N; Saghayam S; Ezhilarasi C; Pujari S, 2015, 'HIV and aging: Insights from the Asia Pacific HIV Observational Database (APHOD)', HIV Medicine, vol. 16, pp. 152 - 160, http://dx.doi.org/10.1111/hiv.12188

James K; Al-Ali S; Tarn J; Cockell SJ; Gillespie CS; Hindmarsh V; Locke J; Mitchell S; Lendrem D; Bowman S; Price E; Pease CT; Emery P; Lanyon P; Hunter JA; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Hall F; Bacabac EC; Chadravarty K; Lamabadusuriya S; Adeniba R; Hamburger J; Richards A; Rauz S; Brailsford S; Logan J; Mulherin D; Andrews J; McManus A; Booth A; Dimitroulas T; Kadiki L; Kaur D; Kitas G; Lloyd M; Moore L; Gordon E; Lawson C; Stirton L; Ortiz G; Clunie G; Rose G; Cuckow S; Knight S; Symmons D; Jones B; Carr A; Collins K; Corbett I; Downie C; Edgar S; Carrozzo M; Figuereido F; Foggo H; Hackett K; Macleod I; Mawson P; Natasari A; Stocks P; Jones A; Muir A; White P; Pugmire S; Watkins M; Field A; Kaye S; Mewar D; Medcalf P; Tomlinson P; Whiteside D; Pauling J; James J; Olaitan N; McDermott J; Godia O; Kidd E; Palmer L; Katsande V; Long P; Li C; Chandra U; MacKay K; Fedele S, 2015, 'A transcriptional signature of fatigue derived from patients with primary Sjögren's syndrome', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0143970

Langton-Lockton J; Hesse K; Carr A; Field AS; Hillman RJ, 2015, 'P10.04 A new paradigm for follow-up of men with anal squamous cell cancer (ascc)', Sexually Transmitted Infections, vol. 91, pp. A166.1 - A166, http://dx.doi.org/10.1136/sextrans-2015-052270.432

Lee FJ; Amin J; Carr A, 2015, 'Limited reporting of major harms in studies of initial combination antiretroviral therapy: A systematic review', AIDS, vol. 29, pp. 921 - 929, http://dx.doi.org/10.1097/QAD.0000000000000633

Lee FJ; Carr A, 2015, 'Dyslipidemia in hiv-infected patients', Dyslipidemias: Pathophysiology, Evaluation and Management, pp. 155 - 176, http://dx.doi.org/10.1007/978-1-60761-424-1_9

McManus H; Petoumenos K; Brown K; Baker D; Russell D; Read T; Smith D; Wray L; Giles M; Hoy J; Carr A; Law MG; Australian HIV Observational Database , 2015, 'Loss to follow-up in the Australian HIV Observational Database', Antiviral Therapy, vol. 20, pp. 731 - 741, http://dx.doi.org/10.3851/IMP2916

Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Sabin CA; Phillips A; Weber R; Pradier C; d'Arminio Monforte A; Dabis F; El-Sadr WM; De Wit S; Kamara D; Tverland J; Mansfeld M; Nielsen J; Raben D; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Kesselring AM; Friis-Møller N; Kowalska J; Sabin C; Bruyand M; Bower M; Fätkenheuer G; Donald A; Grulich A; Prins JM; Kuijpers TW; Scherpbier HJ; van der Meer JTM; Wit FWMN; Godfried MH; van der Poll T; Nellen FJB; Geerlings SE; van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; van der Valk M; Goorhuis A; Hovius JW; van Eden J; Henderiks A; van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Westerman AM; Jurriaans S; Back NKT; Zaaijer HL; Berkhout B; Cornelissen MTE; Schinkel CJ; Thomas XV; van den Berge M; Stegeman A; Baas S; Hage de Looff L; Versteeg D; Pronk MJH; Ammerlaan HSM; Korsten-Vorstermans EMHM; de Munnik ES; Jansz AR; Tjhie J, 2015, 'Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study', PLoS Medicine, vol. 12, http://dx.doi.org/10.1371/journal.pmed.1001809

Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Aagaard B; Aragon E; Arnaiz J; Borup L; Clotet B; Dragsted U; Fau A; Gey D; Grarup J; Hengge U; Herrero P; Jansson P; Jensen B; Jensen K; Juncher H; Lopez P; Lundgren JD; Matthews C; Mollerup D; Pearson M; Phillips A; Reilev S; Tillmann K; Varea S; Angus B; Babiker A; Cordwell B; Darbyshire J; Dodds W; Fleck S; Horton J; Hudson F; Moraes Y; Pacciarini F; Palfreeman A; Paton N; Smith N; Van Hooff F; Bebchuk J; Collins G; Denning E; DuChene A; Fosdick L; Harrison M; Herman-Lamin K; Krum E; Larson G; Neaton J; Nelson R; Quan K; Quan S; Schultz T; Thompson G; Wyman N; Carey C; Chan F; Cooper D; Courtney-Rodgers D; Drummond F; Harrod M; Jacoby S; Kearney L; Lin E; Pett S; Robson R; Seneviratne N; Stewart M; Watts E; Finley E; Gordin F; Sánchez A; Standridge B; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J; Modlin J; Beral V; Chaisson R; Fleming T; Hill C, 2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0139981

Roberts JM; Jin F; Thurloe JK; Biro C; Poynten IM; Tabrizi SN; Fairley CK; Templeton DJ; Carr AD; Garland SM; Hillman RJ; Cornall AM; Grulich AE; Farnsworth A, 2015, 'High reproducibility of histological diagnosis of human papillomavirus-related intraepithelial lesions of the anal canal', Pathology, vol. 47, pp. 308 - 313, http://dx.doi.org/10.1097/PAT.0000000000000246

Sasson SC; McGill K; Wienholt L; Carr A; Brown D; Kelleher AD; Breit SN; Sewell WA, 2015, 'Retrospective audit of the freeliteTM serum free light chain (SFLC) assay: testing patterns, concordance with serum and urine electrophoresis/immunofixation and correlation with the N latex FLC assay', Pathology, vol. 47, pp. S94 - S94, http://dx.doi.org/10.1097/01.pat.0000461601.28805.d5

Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay', Pathology, vol. 47, pp. 564 - 569, http://dx.doi.org/10.1097/PAT.0000000000000316

Templeton DJ; Wright ST; McManus H; Lawrence C; Russell DB; Law MG; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Allardice K; Baker D; Odgers E; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Ryder N; Taylor S; Cooper D; Carr A; Lee F; McRae K; Hesse K; Finlayson R; Gupta S; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Arvela N; Wray L; Thng C; Foster R; Lu H; Couldwell D; DSmith E; Furner V; Fernando S; Dubbo ; Watson J; Mulhall B; Wright S; Bendall C; Boyd M; Gunathilake M; Payne R; O'Sullivan M; White S; Russell D; Joslin J; Cashman C; Sowden D; Taing K; McGill K; Orth D; Youds D; Kelly M; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; N.Roth J; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K; Morwood K; Roth N; Choong K, 2015, 'Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)', BMC Infectious Diseases, vol. 15, http://dx.doi.org/10.1186/s12879-015-1051-4

Tong WWY; Shepherd K; Garland S; Meagher A; Templeton DJ; Fairley CK; Jin F; Poynten IM; Zaunders J; Hillman RJ; Grulich AE; Kelleher AD; Carr A; Acraman B; Fraissard E; Law C; McGrath P; Mellor R; Norris R; O'Dwyer M; Seeds D; Thompson K; Varma R; Adams M; Biro C; Cornall A; Crampton L; Ekman D; Ellard J; Farnsworth A; Feeney L; Howard K; Hyne S; Law M; Machalek D; McCaffery K; McDonald R; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Roberts J; Schema L; Segelov E; Tabrizi S; Thurloe J; Bailey M; Cunningham P; Fsadni B; Grassi K; Ip S; Lograsso M; McBride K; Merlin K; Munier M-L; Piperias M; Xu Y, 2015, 'Human Papillomavirus 16-Specific T-Cell Responses and Spontaneous Regression of Anal High-Grade Squamous Intraepithelial Lesions', Journal of Infectious Diseases, vol. 211, pp. 405 - 415, http://dx.doi.org/10.1093/infdis/jiu461

Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'P10.10 T-cells in the anal mucosa of men with high-grade squamous intraepithelial lesions', Sexually Transmitted Infections, vol. 91, pp. A168.2 - A168, http://dx.doi.org/10.1136/sextrans-2015-052270.438

Wright ST; Law MG; Cooper DA; Keen P; McDonald A; Middleton M; Woolley I; Kelly M; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Little JL; Smith D; Mincham C; Baker D; Ieroklis V; Templeton DJ; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Taylor S; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Patel A; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Fernando S; Chuah J; Watson J; Lawrence C; Mulhall B; McManus H; Bendall C; Boyd M; Ryder N; Payne R; Russell D; Doyle-Adams S; Sowden D; Taing K; McGill K; Orth D; Youds D; Gibson A; Magon H; Dickson B; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Giles M; Hoy J; Williams J; Nolan D; Robinson J; Morwood K; Choong K; Li PCK; Lee MP; Vanar S; Faridah S; Kamarulzaman A; Choi JY; Vannary B; Ditangco R; Tsukada K; Pujari S; Makane A; Ng OT; Sasisopin AJ, 2015, 'Temporal trends of time to antiretroviral treatment initiation, interruption and modification: Examination of patients diagnosed with advanced HIV in Australia', Journal of the International AIDS Society, vol. 18, http://dx.doi.org/10.7448/IAS.18.1.19463

Bloch M; Tong W; Hoy J; Baker D; Lee F; Richardson R; Carr A, 2014, 'Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks', HIV Medicine, vol. 15, pp. 373 - 380, http://dx.doi.org/10.1111/hiv.12123

Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ, 2014, 'HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research', Journal of NeuroVirology, vol. 20, pp. 258 - 268, http://dx.doi.org/10.1007/s13365-014-0242-x

Duda SN; Farr AM; Lindegren ML; Blevins M; Wester CW; Wools-Kaloustian K; Ekouevi DK; Egger M; Hemingway-Foday J; Cooper DA; Moore RD; McGowan CC; Nash D; Saphonn V; Saramony S; Han N; Lee MP; Zhang F; Bele V; Pujari S; Merati T; Ramadian O; Yuliana F; Yunihastuti E; Oka S; Takano M; Kajindran A; Kamarulzaman A; Low LL; Sim BLH; Capistrano R; Ditangco R; Kuo LH; Wong WW; Chaiwarith R; Khongpattanayothin M; Kiertiburanakul S; Kotarathititum W; Phanuphak P; Piyavong B; Fou E; Ng OT; Choi JY; Han SH; Carr A; Chuah J; Dickson B; Hoy J; Ji J; Norris R; Templeton D; Watson K; Bendall C; Jiamsakul A; Law MG; McManus H; Durier N; Petersen B; Sohn AH; Rodriguez B; Gill MJ; Saag MS; Mugavero MJ; Willig J; Eron JJ; Napravnik S; Kitahata MM; Crane HM; Drozd DR; Sterling TR; Haas D; Bebawy S; Turner M; Gange SJ; Althoff KN; McKaig RG; Justice AC; Freeman AM; Lent C; Van Rompaey SE; Morton L; McReynolds J; Lober WB; Abraham AG; Lau B; Zhang J; Jing Y; Golub E; Modur S; Wong C; Mendes A; Masys DR; Minor B; Wehbe F; Cahn P; Krolewiecki A; Cesar C; Schechter M; Faulhaber JC; Wolff M, 2014, 'Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: Results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration', Journal of the International AIDS Society, vol. 17, http://dx.doi.org/10.7448/IAS.17.1.19045

Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0094858

Lee FJ; Amin J; Carr A, 2014, 'Efficacy of initial antiretroviral therapy for HIV-1 infection in adults: A systematic review and meta-analysis of 114 studies with up to 144 weeks' follow-up', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0097482

Lee FJ; Tong WWY; Richardson R; Mackenzie N; Carr A, 2014, 'Metabolic effects of ritonavir-boosted atazanavir and darunavir in HIV-negative adults: A randomised comparison', Journal of AIDS and Clinical Research, vol. 5, http://dx.doi.org/10.4172/2155-6113.1000284

Mcallister J; Read P; Mcnulty A; Tong W; Ingersoll A; Carr A, 2014, 'Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: Safety, tolerability and adherence', HIV Medicine, vol. 15, pp. 13 - 22, http://dx.doi.org/10.1111/hiv.12075

Peacock A; Bruno R; Martin FH; Carr A, 2014, 'Self-reported physiological and psychological side-effects of an acute alcohol and energy drink dose', Appetite, vol. 76, pp. 60 - 65, http://dx.doi.org/10.1016/j.appet.2014.01.003

Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers R; Alvarez-Uria G; Streinu-Cercel A; Ene L; Wensing A; Reiss P; van Sighem AI; Nelson M; Emery S; Montaner JSG; Lane HC; Larder BA; Reiss P; van Sighem A; Montaner J; Harrigan R; Rinke de Wit T; Hamers R; Sigaloff K; Agan B; Marconi V; Wegner S; Sugiura W; Zazzi M; Streinu-Cercel A; Alvarez-Uria G; Gatell J; Lazzari E; Gazzard B; Nelson M; Pozniak A; Mandalia S; Ruiz L; Clotet B; Staszewski S; Torti C; Lane C; Metcalf J; Perez-Elias M-J; Carr A; Norris R; Hesse K; Vlahakis E; Tempelman H; Barth R; Morrow C; Wood R; Ene L; Dragovic G; Cooper D; Torti C; Baxter J; Monno L; Torti C; Gatell J; Clotet B; Picchio G; deBethune M-P; Perez-Elias M-J, 2014, 'An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes', Journal of Antimicrobial Chemotherapy, vol. 69, pp. 1104 - 1110, http://dx.doi.org/10.1093/jac/dkt447

Romero L; Nieuwenhuijse M; Carr A; Sedrakyan A, 2014, 'Review of clinical outcomes-based anchors of minimum clinically important differences in hip and knee registry-based reports and publications', Journal of Bone and Joint Surgery - American Volume, vol. 96, pp. 98 - 103, http://dx.doi.org/10.2106/JBJS.N.00464

Tong WWY; Hillman RJ; Kelleher AD; Grulich AE; Carr A, 2014, 'Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults', HIV Medicine, vol. 15, pp. 65 - 76, http://dx.doi.org/10.1111/hiv.12080

Guy R; El-Hayek C; Fairley CK; Wand H; Carr A; McNulty A; Hoy J; Bourne C; McAllister J; Tee BK; Baker D; Roth N; Stoove M; Chen M, 2013, 'Opt-Out and Opt-In Testing Increases Syphilis Screening of HIV-Positive Men Who Have Sex with Men in Australia', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0071436

Guy R; Wand H; McManus H; Vonthanak S; Woolley I; Honda M; Read T; Sirisanthana T; Zhou J; Carr A, 2013, 'Antiretroviral treatment interruption and loss to follow-Up in Two HIV Cohorts in Australia and Asia: Implications for 'Test and Treat' Prevention Strategy', AIDS Patient Care and STDs, vol. 27, pp. 681 - 691, http://dx.doi.org/10.1089/apc.2012.0439

Jansson J; Wilson DP; Carr A; Petoumenos K; Boyd MA, 2013, 'Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV', AIDS, vol. 27, pp. 1245 - 1251, http://dx.doi.org/10.1097/QAD.0b013e32835e163d

Mcallister J; Beardsworth G; Lavie E; Macrae K; Carr A, 2013, 'Financial stress is associated with reduced treatment adherence in HIV-infected adults in a resource-rich setting', HIV Medicine, vol. 14, pp. 120 - 124, http://dx.doi.org/10.1111/j.1468-1293.2012.01034.x

Peacock A; Bruno R; Martin FH; Carr A, 2013, 'The Impact of Alcohol and Energy Drink Consumption on Intoxication and Risk-Taking Behavior', Alcoholism: Clinical and Experimental Research, vol. 37, pp. 1234 - 1242, http://dx.doi.org/10.1111/acer.12086

Peacock A; Martin FH; Carr A, 2013, 'Energy drink ingredients. Contribution of caffeine and taurine to performance outcomes', Appetite, vol. 64, pp. 1 - 4, http://dx.doi.org/10.1016/j.appet.2012.12.021

Petoumenos K; Van Leeuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG, 2013, 'Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD)', HIV Medicine, vol. 14, pp. 77 - 84, http://dx.doi.org/10.1111/j.1468-1293.2012.01038.x

Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers RL; Alvarez-Uria G; Streinu-Cercel A; Ene L; Wensing AMJ; DeWolf F; Nelson M; Montaner JS; Lane HC; Larder BA; RDI study group , 2013, 'Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings.', J Antimicrob Chemother, vol. 68, pp. 1406 - 1414, http://dx.doi.org/10.1093/jac/dkt041

Sasson SC; Oon A; Chagantri J; Brew BJ; Carr A, 2013, 'Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report', BMC Infectious Diseases, vol. 13, pp. 396 - 396, http://dx.doi.org/10.1186/1471-2334-13-396

Tong WWY; Jin F; McHugh LC; Maher T; Sinclair B; Grulich AE; Hillman RJ; Carr A, 2013, 'Progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions in HIV-infected and uninfected men', AIDS, vol. 27, pp. 2233 - 2243, http://dx.doi.org/10.1097/QAD.0b013e3283633111

Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; Wit SD; Phillips A; Lundgren JD; Sabin CA; Butcher D; Delforge M; Fanti I; Franquet X; Geffard S; Gras L; Helweg-Larsen J; Hillebregt M; Kamara D; Kjær J; Krum E; McManus H; Meidahl P; Mocroft A; Nielsen J; Powderl W; Rickenbach M; Rode R; Ryom L; Salbøl Brandt R; Schmidt Iversen J; Shortman N; Sjøl A; Smith C; Torres F; Tverland J; Wright S; Zaheri S; de Wolf F; Smidt J; Ristola M; Katlama C; Viard JP; Girard PM; Livrozet JM; Vanhems P; Pradier C; Dabis F; Neau D; Rockstroh J; Schmidt R; Degen O; van Lunzen J; Stellbrink HJ; Staszewski S; Bogner J; Gargalianos P; Kosmidis J; Perdios J; Xylomenos G; Filandras A; Karabatsaki E; Panos G; Sambatakou H; Banhegyi D; Mulcahy F; Burke M; Turner D; Yust I; Hassoun G; Pollack S; Maayan S; Vella S; Esposito R; Mazeu I; Mussini C; Arici C; Pristera R; Gabbuti A; Mazzotta F; Lichtner M; Vullo V; Boer K; Geerlings SE; Godfried MH; Kuijpers TW; Lange JMA; Nellen FJB; Pajkrt D; Prins JM; Scherpbier HJ; Vrouenraets SME; Wit FWMN; van Vugt M, 2013, 'Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study', BMC Infectious Diseases, vol. 13, http://dx.doi.org/10.1186/1471-2334-13-471

Bloch MT; Hoy JF; Cummingham N; Roth N; Bailey M; Pearce D; Watson J; Carr AD, 2012, 'Adherence to HIV treatment guidelines for comorbid disease assessment and inititation of antiretroviral therapy', Journal of Acquired Immune Deficiency Syndrome, vol. 59, pp. 478 - 488, http://dx.doi.org/10.1097/QAI.0b013e31824a5473

Botes LP; Pett SL; Carr AD; Marriott D; Cooper DA; Matthews G; Carbone S; Kumaradevan N; Mchugh L; Hillman R, 2012, 'Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with men.', Sexual Health, vol. 10, pp. 9 - 17, http://dx.doi.org/10.1071/SH11135

Carr A; Hoy J; Pozniak A, 2012, 'The ethics of switch/simplify in antiretroviral trials: Non-inferior or just inferior?', PLoS Medicine, vol. 9, http://dx.doi.org/10.1371/journal.pmed.1001240

Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, vol. 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377

Jansson J; Wilson D; Carr A; Petoumenos K; Boyd M, 2012, 'Currently available medications may not be sufficient for lifelong treatment of HIV', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 15, pp. 4 - 4, http://dx.doi.org/10.7448/IAS.15.6.18077

Koelsch KK, 2012, 'No significant effect of uridine or pravastatin treatment for HIV lip atrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomised trial.', HIV Medicine, vol. 11, pp. 493 - 501, http://dx.doi.org/10.1111/j.1468-1293.2009.00817.x

Lam UT; Yoganathan R; Carr A; Mammucari R; Foster NR, 2012, 'Encapsulation of superparamagnetic iron oxide nanoparticles by the supercritical antisolvent process', Australian Journal of Chemistry, vol. 65, pp. 40 - 44, http://dx.doi.org/10.1071/CH11360

Lee FJ; Carr A, 2012, 'Tolerability of HIV integrase inhibitors', Current Opinion in HIV and AIDS, vol. 7, pp. 422 - 428, http://dx.doi.org/10.1097/COH.0b013e328356682a

Arenas-pinto A; Grant A; Bhaskarin K; Copas A; Carr AD; Worm SW; Martinez E; Reiss P; Dunn ; Weber R; Hoy JF; Weller IV, 2011, 'Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis', Antiviral Therapy, vol. 16, pp. 219 - 226, http://dx.doi.org/10.3851/IMP1739

Botes LP; Jin F; Bourne CP; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews G; Brew BJ; Hillman R, 2011, 'Participants' perspectives of self-collected anal cytological swabs', Sexual Health, vol. 8, pp. 257 - 258, http://dx.doi.org/10.1071/SH10037

Carr AD, 2011, 'Statins as Anti-inflammatory Therapy in HIV Disease?', Journal of Infectious Diseases, vol. 203, pp. 751 - 752, http://dx.doi.org/10.1093/infdis/jiq120

Carr AD, 2011, 'eGFR Slope and Tenofovir Nephrotoxicity', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 56, pp. 95 - 96, http://dx.doi.org/10.1097/QAI.0b013e3182087c08

Carr AG; Mammucari R; Foster NR, 2011, 'A review of subcritical water as a solvent and its utilisation for the processing of hydrophobic organic compounds', Chemical Engineering Journal, vol. 172, pp. 1 - 17, http://dx.doi.org/10.1016/j.cej.2011.06.007

Haskelberg H; Carr AD; Emery S, 2011, 'Bone turnover markers in HIV disease', AIDS Reviews, vol. 13, pp. 240 - 250, http://www.aidsreviews.com/files/2011_13_4_240-250.pdf

Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr A, 2011, 'Lower fat mass and lower bone formation predict greater bone loss with tenofovir in HIV-infected adults', ANTIVIRAL THERAPY, vol. 16, pp. A6 - A7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375900007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hillman R; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, vol. 8, pp. 255 - 256, http://dx.doi.org/10.1071/SH10116

Hoy J; Grund B; Roediger MP; Brar I; Colebunders R; De Castro N; Johnson M; Sharma A; Carr A, 2011, 'Plasma markers of bone loss and bone formation decrease with intermittent antiretroviral therapy and predict change in bone mineral density', ANTIVIRAL THERAPY, vol. 16, pp. A5 - A6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Martin A; Amin J; Emery S; Baker D; Carr AD; Cooper DA; Bloch M, 2011, 'Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or Abacavir-Lamivudine', PLoS One, vol. 6, pp. Article number e26885, http://dx.doi.org/10.1371/journal.pone.0026885

McNulty A; Carr AD, 2011, 'Approach to those placing others at risk of HIV infection in NSW', Internal Medicine Journal, vol. 41, pp. 365 - 365, http://dx.doi.org/10.1111/j.1445-5994.2011.02462.x/pdf

Mcnulty A; Carr A, 2011, 'Approach to those placing others at risk of HIV infection in NSW', Internal Medicine Journal, vol. 41, pp. 365 - 365, http://dx.doi.org/10.1111/j.1445-5994.2011.02462.x

O''connor MB; O Connor C; Horgan M; Carr AD; Cooper DA, 2011, 'Sexual activity of HIV patients', Irish Journal of Medical Science, vol. 180, pp. 777 - 779, http://dx.doi.org/10.1007/s11845-010-0564-5

Wand HC; Carey DL; Calmy A; Law MG; Cooper DA; Emery S; Carr AD, 2011, 'Prospective evidence that HIV lipoatrophy and visceral adiposity are partially independent processes', Open Access Journal of Clinical Trials, vol. 3, pp. 1 - 7, http://dx.doi.org/10.2147/OAJCT.S14359

Wright ST; Carr AD; Woolley I; Giles M; Hoy JF; Cooper DA; Law MG, 2011, 'CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts', Journal of acquired immune deficiency syndromes (1999), vol. 58, pp. 72 - 79, http://dx.doi.org/10.1097/QAI.0b013e318225ba62

Amin J; Martin A; Bloch M; Carr A, 2010, 'Reply to Landman and Soonawala', Clinical Infectious Diseases, vol. 50, pp. 1200 - 1201, http://dx.doi.org/10.1086/651469

Bloch M; Hoy J; Cunningham N; Roth N; Andrianopoulos N; Rayner C; Carr A, 2010, 'Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia', Journal of the International AIDS Society, vol. 13, pp. P172 - P172, http://dx.doi.org/10.1186/1758-2652-13-s4-p172

Calmy A; Fux CA; Delhumeau C; Carr A, 2010, 'Correspondence : Reply to Gazzola et al', Journal of Infectious Diseases, vol. 202, pp. 331 - 332, http://dx.doi.org/10.1086/653585

Carr A; Branch A; Mammucari R; Foster NR, 2010, 'The solubility and solubility modelling of budesonide in pure and modified subcritical water solutions', Journal of Supercritical Fluids, vol. 55, pp. 37 - 42, http://dx.doi.org/10.1016/j.supflu.2010.08.001

Carr A; Hoy J, 2010, 'Low bone mineral density with tenofovir: Does statistically significant mean clinically significant?', Clinical Infectious Diseases, vol. 51, pp. 973 - 975, http://dx.doi.org/10.1086/656418

Carr A; Mammucari R; Foster NR, 2010, 'Particle formation of budesonide from alcohol-modified subcritical water solutions', International Journal of Pharmaceutics, vol. 405, pp. 169 - 180, http://dx.doi.org/10.1016/j.ijpharm.2010.11.042

Carr A; Mammucari R; Foster NR, 2010, 'Solubility and Micronization of Griseofulvin in Subcritical Water', Industrial and Engineering Chemistry Research, vol. 49, pp. 3403 - 3410, http://dx.doi.org/10.1021/ie901189r

Carr AG; Mammucari R; Foster NR, 2010, 'Solubility, solubility modeling, and precipitation of naproxen from subcritical water solutions', Industrial and Engineering Chemistry Research, vol. 49, pp. 9385 - 9393, http://dx.doi.org/10.1021/ie9019825

Martin A; Amin J; Cooper DA; Carr AD; Kelleher AD; Bloch M; Baker D; Woolley I; Emery S, 2010, 'Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial', AIDS, vol. 24, pp. 2657 - 2663, http://dx.doi.org/10.1097/QAD.0b013e32833f147f

Molano M; Tabrizi SN; Garland SM; Roberts JM; MacHalek DA; Phillips S; Chandler D; Hillman RJ; Grulich AE; Jin F; Poynten IM; Templeton DJ; Cornall AM; McCaffery K; Howard K; Farnsworth A; Fairley K; Prestage G; Carr A; Tong W; Law C; Acraman B; Crampton L; Feeney L; Fraissard E; Law M; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Varma R, 2010, 'CpG methylation analysis of hpv16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0160673

Samaras K; Richardson R; Carr AD, 2010, 'Postprandial lipid effects of low-dose ritonavir vs. raltegravir in HIV-uninfected adults', AIDS, vol. 24, pp. 1727 - 1731, http://dx.doi.org/10.1097/QAD.0b013e32833ac7be

Sinn K; Richardson R; Carr AD, 2010, 'Lower arterial stiffness and framingham score after switching abacavir to tenofovir in men at high cardiovascular risk', AIDS, vol. 24, pp. 2403 - 2405, http://dx.doi.org/10.1097/QAD.0b013e32833d568f

Wever K; Van Agtmael MA; Carr A, 2010, 'Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men', Journal of Acquired Immune Deficiency Syndromes, vol. 55, pp. 78 - 81, http://dx.doi.org/10.1097/QAI.0b013e3181d05579

Yan C; Hanafi I; Kelleher AD; Carr AD; Amin J; Mcnally L; Cunningham PH, 2010, 'Lack of correlation between three commerical platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification', Journal of Clinical Virology, vol. 49, pp. 249 - 253, http://dx.doi.org/10.1016/j.jcv.2010.08.016

Calmy A; Fux C; Norris R; Vallier N; Delhumeau C; Samaras K; Hesse K; Hirschel B; Cooper DA; Carr AD; Hesse , 2009, 'Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study', Journal of Infectious Diseases, vol. 200, pp. 1746 - 1754, http://dx.doi.org/10.1086/644785

Calmy A; Gayet-Ageron A; Montecucco F; Nguyen A; Mach F; Burger F; Ubolyam S; Carr A; Ruxungtham K; Hirschel B; Ananworanich J, 2009, 'HIV increases markers of cardiovascular risk: Results from a randomized, treatment interruption trial', AIDS, vol. 23, pp. 929 - 939, http://dx.doi.org/10.1097/QAD.0b013e32832995fa

Calmy A; Hirschel B; Cooper DA; Carr AD, 2009, 'A new era of antiretroviral drug toxicity', Antiviral Therapy, vol. 14, pp. 165 - 179

Carey DL; Baker D; Petoumenos K; Chuah J; Rogers G; Watson J; Cooper DA; Emery S; Carr AD, 2009, 'Poly-L-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up', HIV Medicine, vol. 10, pp. 163 - 172, http://dx.doi.org/10.1111/j.1468-1293.2008.00667.x

Carr AD; Amin J, 2009, 'Efficacy and tolerability of initial antiretroviral therapy: A systematic review', AIDS, vol. 23, pp. 343 - 353, http://dx.doi.org/10.1097/QAD.0b013e32831db232

Grund B; Peng G; Gibert C; Hoy JF; Isaksson R; Shlay J; Martinez E; Reiss P; Visnegarwala F; Carr AD, 2009, 'Continuous antiretroviral therapy decreases bone mineral density', AIDS, vol. 23, pp. 1519 - 1529, http://dx.doi.org/10.1097/QAD.0b013e32832c1792

Martin A; Bloch MT; Amin J; Baker DL; Cooper DA; Emery S; Carr AD, 2009, 'Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial', Clinical Infectious Diseases, vol. 49, pp. 1591 - 1601, http://dx.doi.org/10.1086/644769

Mitsuyasu RT; Merigan T; Carr AD; Zack J; Winters M; Workman C; Bloch MT; Lalezari J; Becker S; Thornton L; Akil B; Khanlou H; Finlayson R; Mcfarlane R; Smith DE; Garsia R; Ma DD; Law MG; Murray JM; Von Kalle C; Ely JA; Patino S; Knop A; Wong P; Todd A; Haughton M; Fuery C; Marcpherson J; Symonds G; Evans L; Pond SM; Cooper DA, 2009, 'Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells', Nature Medicine, vol. 15, pp. 285 - 292, http://dx.doi.org/10.1038/nm.1932

O'Connor MB; O'Connor C; Saunders JA; Sheehan C; Murphy E; Horgan M; Carr A; Cooper DA, 2009, 'HIV positive: Who do they tell?', International Journal of STD and AIDS, vol. 20, pp. 517 - 518, http://dx.doi.org/10.1258/ijsa.2009.009146

Samaras K; Gan SK; Peake PW; Carr AD; Campbell LV, 2009, 'Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection', Obesity, vol. 17, pp. 53 - 59, http://dx.doi.org/10.1038/oby.2008.500

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2009, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism', Current HIV Research, vol. 7, pp. 454 - 461, http://dx.doi.org/10.2174/157016209788680589

Boyd MA; Truman M; Holes G; Anderson JA; Dwyer DE; Carr AD, 2008, 'A randomized study to evaluate injection site reactions using three different enfuvirtide delivery mechanisms (the OPTIONS study)', Antiviral Therapy, vol. 13, pp. 449 - 453

Calmy A; Carey DL; Mallon PW; Wand HC; Law MG; Cooper DA; Carr AD, 2008, 'Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy', HIV Medicine, vol. 9, pp. 101 - 110, http://dx.doi.org/10.1111/j.1468-1293.2007.00527.x

Carr AD, 2008, 'Pathogenesis of cardiovascular disease in HIV infection', Current opinion in HIV & AIDS, vol. 3, pp. 234 - 239, http://dx.doi.org/10.1097/COH.0b013e3282fb7be0

Carr AD; Grund B; Neuhaus J; El-Sadr W; Grandits G; Gibert C; Prineas R, 2008, 'Asymptomatic myocardial ischaemia in HIV-infected adults', AIDS, vol. 22, pp. 257 - 267, http://dx.doi.org/10.1097/QAD.0b013e3282f20a77

Carr AD; Ritzhaupt A; Zhang W; Zajdenverg R; Workman C; Gatell J; Cahn PE; Chaves R, 2008, 'Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults', AIDS, vol. 22, pp. 2313 - 2321, http://dx.doi.org/10.1097/QAD.0b013e328315a7a5

El-Sadr W; Grund B; Neuhaus J; Babiker AG; Cohen C; Darbyshire JH; Emery S; Phillips A; Lundgren JD; Neaton JD, 2008, 'Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial', Annals of Internal Medicine, vol. 149, pp. 289 - W62, http://dx.doi.org/10.7326/0003-4819-149-5-200809020-00003

Emery S; Neuhaus J; Phillips A; Babiker AG; Cohen C; Gatell J; Girard P; Grund B; Law MG; Losso MH; Palfreeman A; Wood R, 2008, 'Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study', Journal of Infectious Diseases, vol. 197, pp. 1133 - 1144, http://dx.doi.org/10.1086/586713

Lundgren JD; Babiker AG; El-Sadr W; Emery S; Grund B; Neaton JD; Neuhaus J; Phillips A, 2008, 'Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up', Journal of Infectious Diseases, vol. 197, pp. 1145 - 1155, http://dx.doi.org/10.1086/529523

Mallon PW; Sedwell R; Rogers GJ; Nolan D; Unemori P; Hoy JF; Samaras K; Kelleher AD; Emery S; Cooper DA; Carr AD, 2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction', Journal of Infectious Diseases, vol. 198, pp. 1794 - 1803, http://dx.doi.org/10.1086/593179

Monforte A; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law MG; de Witt S; Friis-Moller N; Phillips AN; Sabin C; Lundgren JD, 2008, 'HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.', AIDS, vol. 22, pp. 2143 - 2153, http://dx.doi.org/10.1097/QAD.0b013e3283112b77

Phillips AN; Carr AD; Neuhaus J; Visnegarwala F; Prineas R; Burman W; Williams IR; Drummond F; Duprez D; Belloso WH; Goebel F; Grund B; Hatzakis A; Vera J; Lundgren JD, 2008, 'Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial', Antiviral Therapy, vol. 13, pp. 177 - 187

Arenas-Pinto A; Copas A; Weller I; Grant A; Dunn D; Bhaskaran K; Carr A; Reiss P; Edwards S; Worm SW; Overton T; Martinez E; Hoy J; Cahn P; Weber R, 2007, 'Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy', AIDS, vol. 21, pp. 2455 - 2464, http://dx.doi.org/10.1097/QAD.0b013e3282f08cdc

Boyd MA; Truman M; Hales GP; Anderson JS; Dwyer DE; Carr AD, 2007, 'A randomized study to evaluate injection site reactions (ISR) using three different mechanisms for delivery of enfuvirtide (ENF): a 27-gauge needle, a 31-gauge needle and a needle-free device', Antiviral Therapy, vol. 12, pp. L57 - L57, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249773400105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Calmy A; Hirschel B; Cooper DA; Carr AD, 2007, 'Clinical update: adverse effects of antiretroviral therapy', Lancet, vol. 370, pp. 12 - 14, http://dx.doi.org/10.1016/S0140-6736(07)61027-7

Calmy A; Petoumenos K; Lewden C; Law MG; Bocquentin F; Hesse K; Cooper DA; Carr AD; Bonnet F, 2007, 'Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts', HIV Medicine, vol. 8, pp. 171 - 180, http://dx.doi.org/10.1111/j.1468-1293.2007.00448.x

Carey DL; Baker D; Rogers G; Petoumenos K; Chuah J; Easey N; Mahon K; Cooper DA; Emery S; Carr AD, 2007, 'A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 46, pp. 581 - 589, http://dx.doi.org/10.1097/QAI.0b013e318158bec9

Carr A, 2007, 'Treatment strategies for HIV lipodystrophy', Current Opinion in HIV and AIDS, vol. 2, pp. 332 - 338, http://dx.doi.org/10.1097/COH.0b013e3281df2b57

Carr AD; Zajdenverg R; Workman C; Gatell J; Cahn PE; Ritzhaupt A; Zhang W; Chaves R, 2007, 'Effects of tipranavir/r (500/200 or 500/100 mg BID) in comparison with lopinavir/r (400/100 ing BID) on changes in body composition and metabolic parameters in ARV-naive patients over 48 weeks', Antiviral Therapy, vol. 12, pp. L8 - L9, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249773400029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Ellis KJ; Grund B; Visnegarwala F; Thackeray L; Miller CG; Chesson CE; El-Sadr W; Carr A, 2007, 'Visceral and subcutaneous adiposity measurements in adults: Influence of measurement site', Obesity, vol. 15, pp. 1441 - 1447, http://dx.doi.org/10.1038/oby.2007.172

Fox Z; Antunes F; Davey R; Gazzard B; Klimas N; Labriola A; Losso M; Neaton JD; Phillips A; Ruxrungtham K; Staszewski S; Weiss L; Lundgren DJ; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ferrari I; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lanusse I; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; Sanchez MDL; Somenzini C; Tocci M; Algar S; Anderson J; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Britton P; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Egan C; Ferguson W; Finlayson R; French M; Frater A; Gold J; Habel P; Haig K; Holland R; Hyland N; Hoy J; Hudson J; James R; Leung J; Lowe K; MacRae K; McMurchie M; Medland N; Miller S; Murray J; Newman R; David O; Patching J; Primrose R; Ree H; Richardson R; Rogers G; Roney J; Roth N; Sarangapany J; Shaw D; Silberberg C; Skett A; Vale R; Villella C; Walker A; Watson A; Wendt N; Wood H, 2007, 'Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2', HIV Medicine, vol. 8, pp. 112 - 123, http://dx.doi.org/10.1111/j.1468-1293.2007.00440.x

May M; Sterne JA; Shipley M; Brunner E; d Agostino R; Whincup P; Ben-Shlomo Y; Carr AD; Ledergerber B; Lundgren JD; Phillips A; Massaro J; Eggerl M, 2007, 'A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men', International Journal of Epidemiology, vol. 36, pp. 1309 - 1318, http://dx.doi.org/10.1093/ije/dym135

Prineas R; Roediger M; Carr AD; El-Sadr W; Esser S; Grandits G; Knysz B; Palfreeman A, 2007, 'Effect of alternate treatment protocols on the incidence of electrocardiographic abnormalities among HIV-infected adults in the SMART trial', Antiviral Therapy, vol. 12, pp. L11 - L11, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249773400033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Erratum: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (Diabetes Care (2007) 30, (113-119))', Diabetes Care, vol. 30, pp. 455, http://dx.doi.org/10.2337/dc07-er02

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2007, 'Prevalence of Metabolic Syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria', Diabetes Care, vol. 30, pp. 113 - 119, http://dx.doi.org/10.2337/dc06-1075

Wand HC; Calmy A; Carey DL; Samaras K; Carr AD; Law MG; Cooper DA; Emery S, 2007, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', AIDS, vol. 21, pp. 2445 - 2453, http://dx.doi.org/10.1097/QAD.0b013e3282efad32

Bloch MT; Smith DE; Quan D; Kaldor JM; Zaunders J; Petoumenos K; Irvine K; Law MG; Grey PA; Finlayson R; Mcfarlane R; Kelleher AD; Carr AD; Cooper DA, 2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 42, pp. 192 - 202, http://dx.doi.org/10.1097/01.qai.0000219779.50668.e6

Boyd MA; Carr AD; Ruxrungtham K; Srasuebkul P; Bien D; Law MG; Wangsuphachart S; Krisanachinda A; Lerdlum S; Lange J; Phanuphak P; Cooper DA; Reiss P, 2006, 'Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to Ritonavir-boosted Indinavir and Efavirenz', Journal of Infectious Diseases, vol. 194, pp. 642 - 650, http://dx.doi.org/10.1086/505709

Calmy A; Carey DL; Mallon PW; Wand HC; Cooper DA; Law MG; Carr AD, 2006, 'Early changes in adiponectin and leptin levels predict changes in limb fat mass over 2 years following initiation of antiretroviral therapy', Antiviral Therapy, vol. 11, pp. L12 - L12, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241975800038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Carr A; Ory D, 2006, 'Does HIV cause cardiovascular disease?', PLoS Medicine, vol. 3, pp. 1986 - 1987, http://dx.doi.org/10.1371/journal.pmed.0030496

Carr AD, 2006, 'Investigating new antiretroviral combinations', Journal of Infectious Diseases, vol. 193, pp. 1742 - 1742, http://dx.doi.org/10.1086/504296

Collins S; Mertenskoetter T; Loeliger E; Tressler R; Weller I; Friis-Møller N; Worm SW; Sabin CA; Sjøl A; Lundgren JD; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Weber R; Reisswafaamel-Sadr P; Kirk O; Dabis F; Law MG; Pradier C; De Wit S; Akerlund B; Calvo G; Monforte ADA; Ledergerber B; Phillips AN; De Wolf F; Zaheri S; Bronsveld W; Hillebrand-Haverkort ME; Prins JM; Bos JC; Schattenkerk JKME; Geerlings SE; Godfried MH; Lange JMA; Van Leth FC; Lowe SH; Van Der Meer JTM; Nellen FJB; Pogány K; Van Der Poll T; Reiss P; Ruys TA; Sankatsing SU; Steingrover R; Van Twillert G; Van Der Valk M; Van Vonderen MGA; Vrouenraets SME; Van Vugt MV; Wit FWMN; Van Eeden A; Ten Veen JH; Van Dam PS; Roos JC; Brinkman K; Frissen PHJ; Weigel HM; Mulder JW; Van Gorp ECM; Meenhorst PL; Mairuhu ATA; Veenstra J; Danner SA; Van Agtmael MA; Claessen FAP; Perenboom RM; Rijkeboer A; Richter C; Van Der Berg J; Van Leusen R; Vriesendorp R; Jeurissen FJF; Kauffmann RH; Koger ELW; Bravenboer B; Ten Napel CHH; Kootstra GJ; Sprenger HG; Miesen WMAJ; Doedens R; Scholvinck EH; Ten Kate RW; Van Houte DPF; Polee M; Kroon FP; Van Den Broek PJ; Van Dissel JT; Schippers EF; Schreij G; Van De Geest S, 2006, 'Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D Study', Archives of Internal Medicine, vol. 166, pp. 1632 - 1641, http://dx.doi.org/10.1001/archinte.166.15.1632

Hamlyn E; McAllister J; Winston A; Sinclair B; Amin J; Carr AD; Cooper DA, 2006, 'Is screening for sexually transmitted infections in men who have sex with men who receive non-occupational HIV post-exposure prophylaxis worthwhile?', Sexually Transmitted Infections, vol. 82, pp. 21 - 23, http://dx.doi.org/10.1136/sti.2005.014662

Law MG; Puls R; Cheng A; Cooper DA; Carr AD, 2006, 'Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults', Antiviral Therapy, vol. 11, pp. 179 - 186

Mallon PW; Miller JE; Kovacic JC; Kent-Hughes J; Norris RP; Samaras K; Feneley MP; Cooper DA; Carr AD, 2006, 'Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men - a randomized, placebo-controlled study', AIDS, vol. 20, pp. 1003 - 1010, http://dx.doi.org/10.1097/01.aids.0000222072.37749.5a

Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, vol. 7, pp. 70 - 85, http://dx.doi.org/10.1310/4733-ACQF-F3P4-2QAC

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2006, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition and metabolic parameters', Antiviral Therapy, vol. 11, pp. L23 - L24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241975800055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Winston A; Amin J; Marriott D; Mallon PW; Carr AD; Cooper DA; Emery S, 2006, 'Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy', HIV Medicine, vol. 7, pp. 105 - 111, http://dx.doi.org/10.1111/j.1468-1293.2006.00349.x

Behrens GMN; Grinspoon S; Carr A, 2005, 'Cardiovascular risk and body-fat abnormalities in HIV-infected adults [4] (multiple letters)', New England Journal of Medicine, vol. 352, pp. 1721 - 1722, http://dx.doi.org/10.1056/NEJM200504213521620

Carey DL; Wand HC; Martin A; Rothwell S; Emery S; Cooper DA; Carr AD, 2005, 'Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial', AIDS, vol. 19, pp. 1325 - 1327, http://dx.doi.org/10.1097/01.aids.0000180106.11383.cc

El-Sadr W; Mullin C; Carr AD; Gibert C; Rappoport C; Visnegarwala F; Grunfeld C; Raghavan S, 2005, 'Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort', HIV Medicine, vol. 6, pp. 114 - 121, http://dx.doi.org/10.1111/j.1468-1293.2005.00273.x

Grinspoon S; Carr A, 2005, 'Cardiovascular risk and body-fat abnormalities in HIV-infected adults', New England Journal of Medicine, vol. 352, pp. 48 - 62, http://dx.doi.org/10.1056/NEJMra041811

Grinspoon SK; Carr AD, 2005, 'Cardiovascular risk and body-fat abnormalities in HIV-infected adults - Reply', New England Journal of Medicine, vol. 352, pp. 1722 - 1722, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000228515200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Grinspoon SK; Carr AD, 2005, 'Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults', New England Journal of Medicine, vol. 352, pp. 48 - 62, http://dx.doi.org/10.1056/NEJMra041811

Kovacic JC; Martin A; Carey DL; Wand HC; Mallon PW; Feneley MP; Emery S; Cooper DA; Carr AD, 2005, 'Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy', Antiviral Therapy, vol. 10, pp. 135 - 143

Lim H; Sedwell R; Duarte NL; Cooper DA; Kelleher AD; Carr AD; Mallon PW, 2005, 'Nucleoside reverse transcriptase inhibitor effects on adipocyte mitochondrial DNA quantity and quality in vitro', Antiviral Therapy, vol. 10, pp. L41 - L42, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235133100081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Macpherson JL; Boyd MP; Arndt AJ; Todd AV; Ganning GC; Ely JA; Elliott F; Knop A; Raponi M; Murray JM; Gerlach W; Sun L; Penny R; Symonds GP; Carr AD; Cooper DA, 2005, 'Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients', Journal of Gene Medicine, vol. 7, pp. 552 - 564, http://dx.doi.org/10.1002/jgm.705

Mallon PW; Miller JM; Kovacic JC; Kent-Hughes J; Norris RP; Samaras K; Feneley MP; Cooper DA; Carr AD, 2005, 'Changes in body composition and cardiovascular measures in hypercholesterolaemic HIV-infected men treated with pravastatin: a randomized, placebo-controlled study', Antiviral Therapy, vol. 10, pp. L15 - L16, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235133100040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Mallon PW; Sedwell R; Unemori P; Kelleher AD; Cooper DA; Carr AD, 2005, 'Methodological considerations in human studies of gene expression in HIV-associated lipodystrophy', Antiviral Therapy, vol. 10, pp. M101 - M108

Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2005, 'In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA', Journal of Infectious Diseases, vol. 191, pp. 1686 - 1696, http://dx.doi.org/10.1086/429697

Mallon PW; Wand HC; Law MG; Miller J; Cooper DA; Carr AD, 2005, 'Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia.', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 38, pp. 156 - 162, http://dx.doi.org/10.1097/01.qai.0000147527.64863.1a

Petoumenos K; Ringland C, 2005, 'Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database', HIV Medicine, vol. 6, pp. 155 - 163, http://dx.doi.org/10.1111/j.1468-1293.2005.00280.x

Sedwell R; Mallon PW; Duarte NL; Zaunders J; Kelleher AD; Cooper DA; Carr AD, 2005, 'Impaired mitochondrial function induced by NRTIs is only detectable in the monocyte (CD14(+)) subset of human PBMC', Antiviral Therapy, vol. 10, pp. L44 - L45, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235133100087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Shulman N; Moyle G; Carr A; Boyle B, 2005, '12th Conference on Retroviruses and Opportunistic Infections (CROI). February 22-25, 2005; Boston, Massachusetts, USA', HIV Clinical Trials, vol. 6, pp. 169 - 181, http://dx.doi.org/10.1310/EYBU-95QU-J9JM-JC1E

Visnegarwala F; Raghavan S; Mullin C; Bartsch G; Wang J; Kotler DP; Gibert C; Shlay J; Grunfeld C; Carr AD; El-Sadr W, 2005, 'Sex differences in the associations of HIV disease characteristics and body composition in anti retroviral-naive persons', American Journal of Clinical Nutrition, vol. 82, pp. 850 - 856

Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2005, 'Increase in limb fat after nucleoside analogue cessation is not associated with decreased visceral fat and has different risk factors', Antiviral Therapy, vol. 10, pp. L5 - L5, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235133100020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Winston A; Bloch MT; Carr AD; Amin J; Mallon PW; Ray J; Marriott D; Cooper DA; Emery S, 2005, 'Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy', Journal of Antimicrobial Chemotherapy, vol. 56, pp. 380 - 387, http://dx.doi.org/10.1093/jac/dki235

Winston A; McAllister J; Amin J; Cooper DA; Carr AD, 2005, 'The use of a triple nucleoside-nucleotide-regimen for occupational HIV post-exposure prophylaxis', HIV Medicine, vol. 6, pp. 191 - 197, http://dx.doi.org/10.1111/j.1468-1293.2005.00288.x

Calmy A; Pascual F; Ford N; Kulwichit W; Carr A, 2004, 'First-line and second-line antiretroviral therapy [7] (multiple letters)', Lancet, vol. 364, pp. 329 - 330

Carey DL; Workman C; Rogers GJ; Baker DA; Martin A; Wand HC; Emery S; Cooper DA; Carr AD, 2004, 'Rosiglitazone for HIV lipoatrophy: 84 weeks follow-up', Antiviral Therapy, vol. 9, pp. L46 - L46, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231616000106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Carr AD, 2004, 'Antiretroviral therapy for previously untreated HIV-1-infected adults:2NN, or just one?', Lancet, vol. 363, pp. 1248 - 1250, http://dx.doi.org/10.1016/S0140-6736(04)16028-5

Carr AD, 2004, 'First-line and second-line antiretroviral therapy - Author`s reply', Lancet, vol. 364, pp. 330 - 330, http://dx.doi.org/10.1016/S0140-6736(04)16718-4

Carr AD; Wand HC, 2004, 'Rosiglitazone for HIV-1 Lipoatrophy', The Lancet, vol. 363, pp. 1829 - 1829, http://dx.doi.org/10.1016/S0140-6736(04)16319-8

Carr AD; Wand HC, 2004, 'Rosiglitazone for HIV-1 lipoatrophy - Reply', Lancet, vol. 363, pp. 1829 - 1829, http://dx.doi.org/10.1016/S0140-6736(04)16319-8

Carr AD; Workman C; Carey DL; Rogers GJ; Martin A; Baker DA; Wand HC; Law MG; Samaras K; Emery S; Cooper DA, 2004, 'No effect of rosiglitazone for treatment of HIV-1 lipoatrophy:randomised, double-blind, placebo-controlled trial', Lancet, vol. 363, pp. 429 - 438, http://dx.doi.org/10.1016/S0140-6736(04)15489-5

Cavalcanti RB; Raboud J; Kain KC; Walmsley S; Carr A; Wand H, 2004, 'Rosiglitazone for HIV-1 lipoatrophy [3] (multiple letters)', Lancet, vol. 363, pp. 1828 - 1829, http://dx.doi.org/10.1016/S0140-6736(04)16318-6

Ellis K; Grund B; Visnegarwala F; Mullin C; Miller C; Chesson C; El-Sadr W; Carr AD, 2004, 'Abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) measurements in HIV+ adults: influences of measurement site', Antiviral Therapy, vol. 9, pp. L34 - L35, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231616000084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Hoy JF; Gahan M; Carr AD; Smith DE; Lewin S; Wesselingh S; Cooper DA, 2004, 'Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir', Journal of Infectious Diseases, vol. 190, pp. 688 - 692, http://dx.doi.org/10.1086/422602

Law MG; Cheng AJ; Cooper DA; Carr AD, 2004, 'Objective evaluation of HIV lipodystrophy case definition in a randomized 96 week clinical trial', Antiviral Therapy, vol. 9, pp. L8 - L9, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231616000040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, vol. 364, pp. 51 - 62, http://dx.doi.org/10.1016/S0140-6736(04)16589-6

Mallon PW; Sedwell R; Unemori P; Merlin K; McGinley C; Ammaranond P; Peperias M; Rafferty M; Williams KM; Samaras K; Morey AL; Chisholm DJ; Kelleher AD; Cooper DA; Carr AD, 2004, 'Nucleoside reverse transcriptase inhibitors (NRTI) decrease adipocyte and monocyte mitochondrial (mt) messenger RNA transcription in the absence of changes in mtDNA or cell morphology', Antiviral Therapy, vol. 9, pp. L56 - L57, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231616000126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Mallon PW; Sedwell R; Unemori P; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'Changes in nuclear gene expression resulting from NRTI-induced inhibition of mitochondrial transcription reveal links between mitochondrial dysfunction and lipid metabolism', Antiviral Therapy, vol. 9, pp. L56 - L56, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231616000125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'In vivo nucleoside reverse transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes independent to HIV infection', Antiviral Therapy, vol. 9, pp. L11 - L11, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231616000044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Martin A; Smith DE; Carr AD; Hoy JF; Chuah J; Mallal SA; Law MG; Clements MS; Cooper DA, 2004, 'Progression of lipodystrophy (LD) with continued thymidine analogue usage: Long-term follow-up from a randomized clinical trial (the PIILR study)', HIV Clinical Trials, vol. 5, pp. 192 - 200, http://dx.doi.org/10.1310/0GU7-6X27-MMHE-5ALE

Martin A; Smith DE; Carr AD; Ringland C; Amin J; Emery S; Hoy JF; Workman C; Doong N; Freund J; Cooper DA, 2004, 'Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study', AIDS, vol. 18, pp. 1029 - 1036, http://dx.doi.org/10.1097/00002030-200404300-00011

Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, vol. 5, pp. 91 - 98, http://dx.doi.org/10.1310/1FLN-8KFC-5HEQ-K19J

Vanhems P; Voirin N; Philippe P; Hirschel B; Brassard J; Carr AD; Cooper DA; Perrin L; Allard R, 2004, 'The incubation period of acute retroviral syndrome as a multistepprocess - A parametric survival analysis', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 37, pp. 1529 - 1533, http://dx.doi.org/10.1097/01.qai.0000131848.20077.eb

Amin J; Moore A; Carr A; French MA; Law M; Emery S; Cooper DA, 2003, 'Combined Analysis of Two-Year Follow-Up from Two Open-Label Randomized Trials Comparing Efficacy of Three Nucleoside Reverse Transcriptase Inhibitor Backbones for Previously Untreated HIV-1 Infection: OzCombo 1 and 2', HIV Research & Clinical Practice, vol. 4, pp. 252 - 261, http://dx.doi.org/10.1310/hct.2003.4.4.004

Amin J; Moore A; Carr AD; French MA; Law MG; Emery S; Cooper DA, 2003, 'Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2', HIV Clinical Trials, vol. 4, pp. 252 - 261, http://dx.doi.org/10.1310/K2U9-QC2V-1Y3V-5DYF

Bisson G; Gross R; Miller V; Weller I; Walker A; Arlett P; Carr A; Evans S; Graham D; Justice A; Kreft-Jais C; Lundgren JD; Munk B; Murray J; Pirmohamed M; Pizzuti D; Szarfman A; Writing group , 2003, 'Monitoring of long-term toxicities of HIV treatments: an international perspective.', AIDS, vol. 17, pp. 2407 - 2417, http://dx.doi.org/10.1097/00002030-200311210-00002

Carr A, 2003, 'Cardiovascular risk factors in HIV-infected patients', Journal of Acquired Immune Deficiency Syndromes, vol. 34, http://dx.doi.org/10.1097/00126334-200309011-00011

Carr A, 2003, 'Lactic acidemia in infection with human immunodeficiency virus', Clinical Infectious Diseases, vol. 36, http://dx.doi.org/10.1086/367565

Carr AD, 2003, 'Cardiovascular risk in HIV infection', Journal of Acquir Immun Defic Syndrome, vol. 34, pp. 73 - 78

Carr AD, 2003, 'Enfuvirtide, an HIV-1 fusion inhibitor', New England Journal of Medicine, vol. 349, pp. 1770 - 1771, http://dx.doi.org/10.1056/NEJM200310303491815

Carr AD, 2003, 'HIV Lipodystrophy: risk factors, pathogenesis, diagnosis and management', AIDS, vol. 17, pp. 141 - 148, http://dx.doi.org/10.1097/00002030-200304001-00017

Carr AD, 2003, 'Lactic acidemia in HIV infection', Clinical Infectious Diseases, vol. 36, pp. 96 - 100

Carr AD, 2003, 'Toxicity of antiretroviral therapy and implications for drug development', Nature Rev Drug Discov, vol. 2, pp. 624 - 634, http://dx.doi.org/10.1038/nrd1151

Carr AD; Emery S; Law MG; Puls R; Lundgren JD; Powderly W, 2003, 'An objective case definition of lipodystrophy in HIV-infected adults: a case-control study', Lancet, vol. 361, pp. 726 - 735, http://dx.doi.org/10.1016/S0140-6736(03)12656-6

Carr AD; Law MG, 2003, 'An objective lipodystrophy severity grading scale using the lipodystrophy case definition score', Journal of Acquired Immune Deficiency Syndrome, vol. 33, pp. 571 - 576, http://dx.doi.org/10.1097/00126334-200308150-00004

Clegg AO; Williamson P; Biti RA; Cooper DA; Emery S; Carr AD; Stewart GJ, 2003, 'Chemokine receptor genotype and response to interleukin-2 therapy in HIB-1-infected individuals', Clinical Immunology, vol. 106, pp. 36 - 40, http://dx.doi.org/10.1016/S1521-6616(02)00020-7

Cunningham PH; Marriott D; Harris C; Hancock S; Carr AD; Cooper DA; Harris C, 2003, 'False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in Thailand', Journal of Clinical Virology, vol. 26, pp. 163 - 169, http://dx.doi.org/10.1016/S1386-6532(02)00115-4

Friis-Møller N; Sabin CA; Weber R; d'Arminio Monforte A; El-Sadr WM; Reiss P; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD; Bartsch G; Dabis F; Houyez F; Loeliger E; Tressler R; Weller I; Sjøl A; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Meester R; Lavignolle V; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Hammer S; Neaton J; de Wolf F; van der Ven E; Zaheri S; Van Valkengoed I; Bronsveld W; Weigel H; Brinkman K; Frissen P; ten Veen J; Hillebrand M; van Dam P; Schieveld S; Mulder J; van Gorp E; Meenhorst P; van Eeden A; Danner S; Claessen F; Perenboom R; Eeftinck Schattenkerk JK; Godfried M; Lange J; Lowe S; van der Meer J; Nellen F; Pogany K; van der Poll T; Prins J; Ruys T; van der Valk M; Wit F; Richter C; van Leusen R; Vriesendorp R; Jeurissen F; Kauffmann R; Koger E; Bravenboer B; ten Napel C; Sprenger HG; Law G; ten Kate RW; Leemhuis M; Kroon F; Schippers E; Schrey G; van der Geest S; Verbon A; Koopmans P; Keuter M; Telgt D; van der Ven A; van der Ende M; Gyssens I; de Marie S; Juttmann J; van der Heul C; Schneider M; Borleffs J; Hoepelman I; Jaspers C; Matute A; Schurink C, 2003, 'Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group', New England Journal of Medicine, vol. 349, pp. 1993 - 2003, http://dx.doi.org/10.1056/NEJMoa030218

Ioannidis JP; Trikalinos TA; Law MG; Carr AD, 2003, 'HIV lipodystrophy case definition using artificial neural network modelling.', Antiviral Therapy, vol. 8, pp. 435 - 441

Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, vol. 4, pp. 241 - 249, http://dx.doi.org/10.1046/j.1468-1293.2003.00152.x

Mallon PW; Cooper DA; Carr AD, 2003, 'Longterm treatment complications. I', AIDS, pp. 127 - 144

Mallon PW; Cooper DA; Carr AD, 2003, 'Metabolic complications of antiretroviral therapy', AIDS and Other Manifestations of HIV Infection, pp. 853 - 868

Mallon PW; Miller J; Cooper DA; Carr AD, 2003, 'Prospective evaluation of the effects of antiretroviral therapy on body composition and metabolic parameters in HIV-1-infected men starting therapy', AIDS, vol. 17, pp. 979, http://dx.doi.org/10.1097/00002030-200305020-00005

Mallon PW; Wand HC; Law MG; Miller JM; Cooper DA; Carr AD, 2003, 'Strong association between buffalo hump and high serum insulin concentrations in HIV-infected individuals', Antiviral Therapy, vol. 8, pp. L61 - L61, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231266500110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Miller J; Carr AD; Emery S; Law MG; Mallal SS; Baker D; Smith DG; Kaldor JM; Cooper DA, 2003, 'HIV lipodystrophy: prevalence, severity and correlates of risk in Australia', HIV Medicine, vol. 4, pp. 293 - 301, http://dx.doi.org/10.1046/j.1468-1293.2003.00159.x

Petoumenos K; Carr AD, 2003, 'The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV Observational database', Journal of Clinical Virology, vol. 26, pp. 209 - 222, http://dx.doi.org/10.1016/S1386-6532(02)00119-1

Puls R; Carr AD, 2003, 'Practical applications of the HIV lipodystrophy case definition', AIDS Reader, vol. 13, pp. 480 - 481

Raghavan S; Mullin C; Bartsch G; Wang J; Kotler DP; Shlay J; Gibert C; Grunfeld C; Carr AD, 2003, 'Association between HIV disease characteristics with total and regional body composition levels in antiretroviral-naive men and women', Antiviral Therapy, vol. 8, pp. L66 - L66, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231266500119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Smith DE; Hudson J; Martin A; Freund J; Griffiths MR; Kalnins S; Law M; Carr A; Cooper DA; Group and Investigators FTPD, 2003, 'Centralized Assessment of Dual-Energy X-ray Absorptiometry (DEXA) in Multicenter Studies of HIV-Associated Lipodystrophy', HIV Research & Clinical Practice, vol. 4, pp. 45 - 49, http://dx.doi.org/10.1310/hct.2003.4.1.006

Smith DE; Hudson J; Martin A; Freund J; Griffiths MR; Kalnins S; Law MG; Carr AD; Cooper DA, 2003, 'Centralised assessment of dual-energy x-ray absorptiometry (DEXA) in multicenter studies of HIV-associated lipodystrophy', HIV Clinical Trials, vol. 4, pp. 45 - 49, http://dx.doi.org/10.1310/WRL8-DWH1-7VQL-AK81

Smith DE; Kaufmann GR; Kahn JO; Hecht FM; Grey PA; Zaunders J; Cunningham PH; Carr AD; Duncombe CJ; Quan D; Petersen A; Cooper DA, 2003, 'Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine and nelfinavir before complete HIV type 1 seroconversion', AIDS Research and Human Retroviruses, vol. 19, pp. 189 - 199, http://dx.doi.org/10.1089/088922203763315696

Smith DG; Carr AD; Law MG; Martin A; Hoy JF; Hudson J; Cooper DA, 2003, 'Thymidine analogue withdrawal for patients on protease sparing therapy improves lipoatrophy but compromises antivrial control:the PIILR extension study', AIDS, vol. 16, pp. 2489 - 2491, http://dx.doi.org/10.1097/00002030-200212060-00020

Vanhems P; Voirin N; Hirschel B; Cooper DA; Vizzard J; Carr A; Perrin L, 2003, 'Incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS', Journal of Acquired Immune Deficiency Syndromes, vol. 32, pp. 542 - 544, http://dx.doi.org/10.1097/00126334-200304150-00012

Vanhems P; Voirin N; Hirschel B; Cooper DA; Vizzard J; Carr AD; Perrin L, 2003, 'Swiss HIV Cohort Study. Incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS', Journal of Acquir Immun Defic Syndrome, vol. 32, pp. 542 - 544

Baker D; Law MG; Petoumenos K; Smith DE; Anderson JA; Roth N; Mallal SA, 2002, 'Rates of combination antiretroviral treatment change in Australia, 1997-2000', HIV Medicine, vol. 3, pp. 28 - 36, http://dx.doi.org/10.1046/j.1464-2662.2001.00094.x

Carr A; Cooper D; Darbyshire J; Dubé M; Peto T; Raghavan S; Reiss P; Walker S; Weller I; Zackin R, 2002, 'The evaluation of metabolic function and fat redistribution in clinical trials', HIV Medicine, vol. 3, pp. 65 - 72, http://dx.doi.org/10.1046/j.1464-2662.2001.00099.x

Carr A; Cooper DA, 2002, 'Fumagillin for intestinal microsporidiosis', NEW ENGLAND JOURNAL OF MEDICINE, vol. 347, pp. 1381 - 1381, http://dx.doi.org/10.1056/NEJM200210243471719

Carr A; Cooper DA; Molina JM; Tourneur M, 2002, 'Fumagillin for intestinal microsporidiosis [4] (multiple letters)', New England Journal of Medicine, vol. 347, pp. 1381, http://dx.doi.org/10.1056/NEJM200210243471719

Carr AD, 2002, 'Improvement of the study, analysis, and reporting of adverse events associated with antiretroviral therapy', The Lancet, vol. 360, pp. 81 - 85, http://dx.doi.org/10.1016/S0140-6736(02)09341-8

Carr AD, 2002, 'Liver dysfunction associated with antiretroviral therapy', HIVINSITE, pp. 1

Carr AD, 2002, 'Virologic outcomes of complex drug regimens for human immunodeficiency virus', Journal of the American Medical Association, vol. 288, pp. 2405 - 2406, http://dx.doi.org/10.1001/jama.288.19.2405-JLT1120-3-1

Carr AD; Amin J; Cooper DA, 2002, 'Insulin resistance and HIV-related lipoatrophy', Journal of the American Medical Association, vol. 288, pp. 1716, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000178484700016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Carr AD; Cooper DA, 2002, 'Fumagillin for microsporidiosis', New England Journal of Medicine, vol. 347, pp. 1381 - 1381

Carr AD; Cooper DA, 2002, 'Fumagillin treatment of intestinal microsporidiosis', New England Journal of Medicine, vol. 347, pp. 1381

Carr AD; Law MG; Baker D; Petoumenos K; Smith D; Anderson JA; Roth N; Mallal SS, 2002, 'Rates of combination antiretroviral treatment change in Australia', HIV Medicine, vol. 3, pp. 28 - 36

Carr AD; Workman C; Smith DE; Hoy JF; Doong N; Amin J; Law MG; Cooper DA, 2002, 'For the MITOX investigators: Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial', Journal of the American Medical Association, vol. 288, pp. 207 - 215

Carr AD; Workman C; Smith DE; Hoy JF; Hudson J; Doong N; Martin A; Amin J; Freund J; Law MG; Cooper DA, 2002, 'Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy', JAMA - Journal of the American Medical Association, vol. 288, pp. 207 - 215, http://dx.doi.org/10.1001/jama.288.2.207

French M; Amin J; Roth N; Carr A; Law M; Emery S; Drummond F; Cooper D; investigators* OBOO2, 2002, 'Randomized, open-Label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: The OzCombo 2 study', HIV Research & Clinical Practice, vol. 3, pp. 177 - 185, http://dx.doi.org/10.1310/hct.2002.3.3.001

French MA; Amin J; Roth N; Law MG; Emery S; Drummond F, 2002, 'Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 infection: The OzCombo 2 Study', HIV Clinical Trials, vol. 3, pp. 177 - 185, http://dx.doi.org/10.1310/9N21-1HG1-7N1Q-JKW1

Gan SK; Samaras K; Thompson CH; Kraegen EW; Carr AD; Cooper DA; Chisholm DJ, 2002, 'Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy', Diabetes, vol. 51, pp. 3163 - 3169, http://dx.doi.org/10.2337/diabetes.51.11.3163

Mallon PW; Carr AD; Cooper DA, 2002, 'HIV-associated lipodystrophy: description, pathogenesis, and molecular pathways', Current Diabetes Reports, vol. 2, pp. 116 - 124, http://dx.doi.org/10.1007/s11892-002-0070-x

Mikhailof N; Carr A; Amin J; Cooper DA, 2002, 'Insulin resistance and HIV-related lipoatrophy [1] (multiple letters)', Journal of the American Medical Association, vol. 288, pp. 1716, http://dx.doi.org/10.1001/jama.288.14.1716

Miller J; Brown DA; Amin J; Kent-Hughes J; Law MG; Cooper DA; Carr AD, 2002, 'A randomised, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia', AIDS, vol. 16, pp. 2195 - 2200, http://dx.doi.org/10.1097/00002030-200211080-00012

Moyle G; Carr A, 2002, 'HIV-associated lipodystropy, metabolic complications, and antiretroviral toxicities', HIV Clinical Trials, vol. 3, pp. 89 - 98

Schambelan M; Benson CA; Carr AD; Currier JS; Dube MP; Gerber JG; Grinspoon SK; Grunfeld C; Kotler DP; Mulligan K; Powderly W; Saag MS, 2002, 'Management of the metabolic complications assoicated with antiretroviral therapy for HIV-1 infection:recommedations of an International AIDS society-USA', Journal of Acquir Immun Defic Syndrome, vol. 31, pp. 257 - 275, http://dx.doi.org/10.1097/00126334-200211010-00001

Smith DE; Carr AD; Law MG; Hudson J; Hoy JF; Cooper DA, 2002, 'Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study', AIDS, vol. 16, pp. 2489 - 2491

Vandems V; Caillat-Vallet E; Hirschel B; Routy J; Carr AD; Vizzard J; Cooper DA; Perrin L, 2002, 'The CD4 cell count 3 months after severe retroviral syndrome is associated with the presence of AIDS in the source individual', AIDS, vol. 16, pp. 2234 - 2236

Vanhems P; Caillat-Vallet E; Hirschel B; Routy J; Carr AD; Vizzard J; Cooper DA; Perrin L, 2002, 'The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual', AIDS, vol. 16, pp. 2234 - 2236, http://dx.doi.org/10.1097/00002030-200211080-00022

Vanhems P; Routy J; Hirschel B; Baratin D; Vora S; Carr AD; Maenza J; Trepo C; Touraine JL; Gillibert R; Collier AC; Cooper DA; Vizzard J; Sekaly R; fabry J; Perrin L, 2002, 'Clinical features of the acute retroviral syndrome differ by route of infection but not by gender and age', Journal of Acquir Immun Defic Syndrome, vol. 31, pp. 318 - 321, http://dx.doi.org/10.1097/00126334-200211010-00007

Wilkinson J; Zaunders J; Carr AD; Guillemin GJ; Cooper DA, 2002, 'Characterization of the phenotypic and lymphokine profile associated with strong CD8+ anti-HIV-1 suppressor activity (CASA', Clinical and Experimental Immunology, vol. 127, pp. 145 - 150, http://dx.doi.org/10.1046/j.1365-2249.2002.01744.x

Blanco F; Carr A, 2001, 'Lipodystrophy syndrome: Diagnostic, clinic and therapeutic aspects', AIDS Reviews, vol. 3, pp. 98 - 105

Carr A, 2001, 'Osteopenia in HIV infection.', AIDS clinical care, vol. 13

Carr A; Morey A; Mallon P; Williams D; Thorburn DR, 2001, 'Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia', Lancet, vol. 357, pp. 1412 - 1414, http://dx.doi.org/10.1016/S0140-6736(00)04579-7

Carr AD; Baker D; Petoumenos K; Law MG; Smith D; Roth N; Anderson JA; Mallal SS, 2001, 'Time trends in antiretroviral treatment use in Australia', Venereology - the Interdisciplinary International Journal of Sexual Health, vol. 14, pp. 162 - 168

Carr AD; Hudson J; Chuah J; Law MG; Mallal SA; Hoy JF; Doong N; French MA; Smith DE; Cooper DA, 2001, 'HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study', AIDS, vol. 15, pp. 1811 - 1822, http://dx.doi.org/10.1097/00002030-200109280-00010

Carr AD; Miller J; Eisman JA; Cooper DA, 2001, 'Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy', AIDS, vol. 15, pp. 703 - 709, http://dx.doi.org/10.1097/00002030-200104130-00005

Gan SK; Samaras K; Carr AD; Chisholm DJ, 2001, 'Anti-retroviral therapy, insulin resistance and lipodystrophy', Diabetes Obesity and Metabolism, vol. 3, pp. 67 - 71, http://dx.doi.org/10.1046/j.1463-1326.2001.00146.x

Mallon PW; Cooper DA; Carr AD, 2001, 'HIV¿associated lipodystrophy.', HIV Medicine, vol. 2, pp. 166 - 173, http://dx.doi.org/10.1046/j.1468-1293.2001.00071.x

Mooser V; Carr A, 2001, 'Antiretroviral therapy-associated hyperlipidaemia in HIV disease', Current Opinion in Lipidology, vol. 12, pp. 313 - 319, http://dx.doi.org/10.1097/00041433-200106000-00011

Powderly WG; Carr A, 2001, 'AIDS 2001. Clinical treatment. Overview.', AIDS, vol. 15 Suppl 5

Powderly WG; Carr A, 2001, 'Clinical treatment', AIDS, vol. 15, http://dx.doi.org/10.1097/00002030-200100005-00019

Sabin CA; Olmscheid B; Moyle G; Carr A; Boyle B; Cohen C; Cooper D; Deeks S; Gulick T; Saag M, 2001, 'Selected topics from the 8th Conference on Retroviruses and Opportunistic Infections. February 4-8, 2001. Chicago, Illinois.', HIV Clin Trials, vol. 2, pp. 366 - 386, http://dx.doi.org/10.1310/FPDY-DK6J-GLTV-HC50

Zaunders J; Kaufmann GR; Cunningham PH; Smith DE; Grey PA; Suzuki K; Carr AD; Goh L; Cooper DA, 2001, 'Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.', Journal of Infectious Diseases, vol. 183, pp. 736 - 743, http://dx.doi.org/10.1086/318827

Carr A, 2000, 'HIV protease inhibitor-related lipodystrophy syndrome', Clinical Infectious Diseases, vol. 30, http://dx.doi.org/10.1086/313854

Carr A, 2000, 'Lipodystrophy syndrome: Developing a case definition', AIDS, vol. 14, pp. S13 - S13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000165192300040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carr A; Morey A; Cooper DA; Thorburn DR, 2000, 'Chronic liver failure and persistent mitochondrial dysfunction 2 years after nucleoside reverse transcriptase inhibitor (NRTI)-induced acute hepatitis and lactic acidemia', AIDS, vol. 14, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000165192300211&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carr A; Yarchoan R, 2000, 'AIDS 2000. Clinical treatment: overview.', AIDS, vol. 14 Suppl 3

Carr AD; Chuah J; Hudson J; French MA; Hoy JF; Law MG; Sayer D; Emery S; Cooper DA; On BOTC, 2000, 'A randomised, open-label comparison of three highly active antiretroviral therapy regimes including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study', AIDS, vol. 14, pp. 1171 - 1180, http://dx.doi.org/10.1097/00002030-200006160-00014

Carr AD; Cooper DA, 2000, 'Adverse effects of antiretroviral therapy', Lancet, vol. 356, pp. 1423 - 1430, http://dx.doi.org/10.1016/S0140-6736(00)02854-3

Carr AD; Mills J; Law MG; Cooper DA, 2000, 'A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome', AIDS, vol. 14, pp. 25 - 32, http://dx.doi.org/10.1097/00002030-200002180-00001

Kaufmann GR; Zaunders J; Kelleher AD; Grey PA; Smith DE; Carr AD; Cooper DA, 2000, 'Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection', AIDS, vol. 14, pp. 2543 - 2551, http://dx.doi.org/10.1097/00002030-200012010-00003

Mills J; Carr AD; Smith DE; Emery S; Law MG; Grey PA; Cooper DA, 2000, 'Lipodystrophy following antiretroviral therapy of primary HIV infection (letter)', AIDS, vol. 14, pp. 2406 - 2407, http://dx.doi.org/10.1097/00002030-200010200-00025

Rhodes DI; Ashton LJ; Solomon A; Carr AD; Cooper DA; Kaldor JM; Deacon N; For TAL-T, 2000, 'Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression', Journal of Virology, vol. 74, pp. 10581 - 10588, http://dx.doi.org/10.1128/JVI.74.22.10581-10588.2000

Sobanski MA; Barnes RA; Gray SJ; Carr AD; Kaczmarski EB; O'Rourke A; Murphy K; Cafferkey M; Ellis RW; Pidcock K; Hawtin P; Coakley WT, 2000, 'Measurement of serum antigen concentration by ultrasound-enhanced immunoassay and correlation with clinical outcome in meningococcal disease', EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, vol. 19, pp. 260 - 266, http://dx.doi.org/10.1007/s100960050473

Baker R; Kotler D; Carr A; Torres RA, 1999, 'Altered body shape in HIV disease: A side effect of therapy?', AIDS Patient Care and STDs, vol. 13, pp. 395 - 402, http://dx.doi.org/10.1089/apc.1999.13.395

Bloch M; Carr AD; Vasak E; Cunningham PH; Smith DD; Penny R, 1999, 'The use of human immunodeficiency virus postexposure prophylaxis following successful artificial insemination', American Journal of Obstetrics and Gynecology, vol. 181, pp. 760 - 761

Bloch M; Carr AD; Vasak E; Cunningham PH; Smith DE, 1999, 'The use of human immunodeficiency virus post exposure prophylaxis after success-ful artificial insemination.', American Journal of Obstetrics and Gynecology, vol. 181, pp. 760 - 761, http://dx.doi.org/10.1016/S0002-9378(99)70529-6

Carr AD, 1999, 'HIV nucleoside analogues: new adverse effects on mitochondria', Lancet, vol. 354, pp. 1046 - 1047, http://dx.doi.org/10.1016/S0140-6736(99)00301-3

Carr AD, 1999, 'Protease inhibitor-induced lipodystrophy', AIDS Reviews, vol. 1, pp. 29 - 36

Carr AD; Samaras K; Thorisdottir A; Kaufmann GR; Chisholm DJ; Cooper DA, 1999, 'Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitis: a cohort study', The Lancet, vol. 353, pp. 2093 - 2099, http://dx.doi.org/10.1016/S0140-6736(98)08468-2

Cooper DA; Penny R; Symonds G; Carr AD; Gerlach W; Sun L; Ely JA, 1999, 'A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins', Human Gene Therapy, vol. 10, pp. 1401 - 1421, http://dx.doi.org/10.1089/10430349950018067

Freund J; Carr A; Samaras K; Law M; Chisholm DJ; Cooper DA; Griffiths MR; Majerovic Y; Noakes KA, 1999, 'Peripheral lipodystrophy measured by DEXA in patients receiving HIV protease inhibitors', Nuclear Medicine Communications, vol. 20, pp. 390 - 390, http://dx.doi.org/10.1097/00006231-199904000-00104

Freund J; Griffiths MR; Majerovic Y; Noakes KA; Carr A; Cooper D, 1999, 'Skeletal display versus skeletal and soft tissue display analysis of whole-body composition', Nuclear Medicine Communications, vol. 20, pp. 380 - 380, http://dx.doi.org/10.1097/00006231-199904000-00072

Kaufmann GR; Cunningham PH; Zaunders J; Law MG; Vizzard J; Carr AD; Cooper DA, 1999, 'Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection', Journal of acquired immune deficiency syndrome and human retrovirology, vol. 22, pp. 437 - 444

Vanhems P; Dassa C; Lambert J; Cooper DA; Perrin L; Vizzard J; Hirschel B; Kinloch-De Loes S; Carr AD; Allard R, 1999, 'Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection', Journal of acquired immune deficiency syndrome and human retrovirology, vol. 21, pp. 99 - 106

Wilkinson JG; Zaunders J; Carr AD; Cooper DA, 1999, 'CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia', Journal of Infectious Diseases, vol. 180, pp. 68 - 75, http://dx.doi.org/10.1086/314833

Zaunders J; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright RH; Smith DE; Grey PA; Vizzard J; Carr AD; Cooper DA, 1999, 'Potent antiretroviral therapy of primary HIV-1 infection: partial normalisation of T lympho-cyte subsets and limited reduction of proviral DNA despite clearance of plasma viremia.', Journal of Infectious Diseases, vol. 180, pp. 320 - 329, http://dx.doi.org/10.1086/314880

Ashton LJ; Carr AD; Cunningham PH; Roggensack M; Mclean K; Law MG; Robertson M; Cooper DA; Kaldor JM, 1998, 'Predictors of progression in long-term nonprogressors.', AIDS Research and Human Retroviruses, vol. 14, pp. 117 - 121, http://dx.doi.org/10.1089/aid.1998.14.117

Carr A; Cooper DA, 1998, 'HIV and AIDS - Gap between biology and reality in AIDS', LANCET, vol. 352, pp. 16 - 16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000077742900016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carr A; Cooper DA, 1998, 'Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor.', The New England journal of medicine, vol. 339, pp. 1296

Carr AD; Cooper DA, 1998, 'Gap between biology and reality in AIDS', Lancet, vol. 352, pp. 16 - 16

Carr AD; Cooper DA, 1998, 'Lipodystrophy associated with an HIV-protease inhibitor', New England Journal of Medicine, vol. 339, pp. 1296 - 1296, http://dx.doi.org/10.1056/NEJM199810293391806

Carr AD; Emery S; Lloyd AR; Hoy JF; Garsia R; French MA; Stewart GA; Fyfe G; Cooper DA, 1998, 'Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, milticenter study', Journal of Infectious Diseases, vol. 178, pp. 992 - 999, http://dx.doi.org/10.1086/515653

Carr AD; Marriott D; Field AS; Vasak E; Cooper DA, 1998, 'Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy', Lancet, vol. 351, pp. 256 - 261, http://dx.doi.org/10.1016/S0140-6736(97)07529-6

Carr AD; Samaras K; Burton S; Law MG; Freund J; Chisholm DJ; Cooper DA, 1998, 'A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors', AIDS, vol. 12, pp. F51 - F58, http://dx.doi.org/10.1097/00002030-199807000-00003

Carr AD; Samaras K; Chisholm DJ; Cooper DA, 1998, 'Abnormal fat distribution and use of protease inhibitors', Lancet, vol. 351, pp. 1736 - 1736, http://dx.doi.org/10.1016/S0140-6736(05)77775-8

Carr AD; Samaras K; Chisholm DJ; Cooper DA, 1998, 'Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance', Lancet, vol. 351, pp. 1881 - 1883, http://dx.doi.org/10.1016/S0140-6736(98)03391-1

Collins S; Carr A; O'Keefe D, 1998, 'Evaluation of the effectiveness of a chronic pain management programme', Irish Journal of Psychology, vol. 19, pp. 283 - 294, http://dx.doi.org/10.1080/03033910.1998.10558191

Kaufmann GR; Cunningham PH; Kelleher AD; Zaunders J; Carr AD; Vizzard J; Law MG; Cooper DA; Catchpole BR; Baker D; Beveridge A; Bloch M; Byrne J; Doong N; Duncombe CJ; Finlayson R; Genn W; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1998, 'Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection', Journal of Infectious Diseases, vol. 178, pp. 1812 - 1815, http://dx.doi.org/10.1086/314480

Kaufmann GR; Duncombe CJ; Cunningham PH; Beveridge A; Carr AD; Sayer D; French MA; Cooper DA, 1998, 'Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals', AIDS, vol. 12, pp. 1625 - 1630, http://dx.doi.org/10.1097/00002030-199813000-00009

Kelleher AD; Roggensack M; Emery S; Carr AD; French MA; Cooper DA, 1998, 'Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens', Clinical and Experimental Immunology, vol. 113, pp. 85 - 91, http://dx.doi.org/10.1046/j.1365-2249.1998.00633.x

McAlinden MG; Magowan J; Wilson DJ; Insley G; Ferris P; Prendergast PJ; Rice J; Blayney AW; Dalstra M; Walsh M; McGloughlin T; Grace P; Colgan D; Bray D; McCormack BAO; Reilly R; Tancred D; Carr AJ; Leyland NS; Meenan J; Boyd A; Akay M; O'Dwyer B; Dunne NJ; Ryan K; Orr JF; Stungo B; Brennan EG; O'Hare NJ; Walsh MJ; Jordan MF; Rasheed AM; Kelly C; Kay E; Bouchier-Hayes DJ; Leahy A; Maher SA; O'Reilly D; Foley J; Gillan MA; Cole JS; Raghunathan S; O'Reilly MJG; Kenny T; Hourigan TF; Lyons GM; Cox SL; Kernohan WG; Fitzpatrick C; Dempsey GJ; Millar I; Kelly S; Charlwood AP; O'Brien S; Beverland DE; Kavanagh A; Neligan MF; McKenna J; Laracy P; Moran D; O'Beirne J; Nixon JR; Kenny P; Maher SA; Murphy LA; O'Rourke SK; O'Donoghue D; Gilchrist MD; Caulfield B; O'Brien B; Simms C; Lyons CG; Brady CL; Badran S; Clifford PM; Burden DJ; Orr JF; Taylor D; Hill R; Griffin S; De Barra E; Brook I; Reytil P; Blades M; O'Reilly JP; Masterson BF; Macauley D; Toner M; Walker J; Gillan J; Meenan J; Murphy H; McNamara P; Jones E; Kelly P; Rajah L, 1998, 'Royal academy of medicine in Ireland section of bioengineering - Proceedings of meeting held in dundalk, co. louth, in february 1998.', Irish Journal of Medical Science, vol. 167, pp. 256 - 276, http://dx.doi.org/10.1007/BF02937426

Ryan BM; McKiernan S; Keeling PWN; Byrne PJ; Quill R; McCallion K; Mitchell RMS; Watson RGP; Collins JSA; Gardiner KR; Winter DC; O'Sullivan GC; Taylor CT; Fanning NF; Redmond HP; O'Donoghue DP; Baird AW; Harvey BJ; Brannigan AE; O'Connell PR; Regan MC; Fitzpatrick JM; Watson RWG; Lemass H; Ryan E; MacMathuna P; Crowe J; O'Keane JC; Goh J; Baird A; Maher L; Godson C; Brady HR; Petasis NA; Fokin VV; Barry MK; Grant DC; Sheahan K; O'Donoghue DP; Hyland JMP; Sheehan KM; O'Donoghue DP; Fitzgerald DJ; Murray FE; Heaney A; Bamford KB; Watson RGP; McFarland RJ; Tham TCK; McNamara D; Franelli S; Whelan H; Hamilton H; Beattie S; O'Morain C; Keeling PWN; Brennan EG; O'Hare N; McDermott R; Byrne PJ; McDougall NI; Gieeson CM; Russell SEH; Sloan JM; Morrisey D; Murphy L; Kiely B; Fitzgerald G; Daly C; O'Sullivan G; Shanahan F; Collins JK; Marteau P; Johnston SD; Watson RGP; Coates C; Feighery C; O'Keeffe J; Whelan A; Lynch S; Weir DG; Abuzakouk M; Barnes L; O'Gorman N; McKenna M; Freaney R; Young M; Gaines S; Brady D; Drudy D; O'Farrelly C; Gilleece A; Fenelon L, 1998, 'Irish society of gastroenterology - Proceedings of meeting held Friday 12th and Saturday 13th June, 1998', Irish Journal of Medical Science, vol. 167, pp. 2 - 22, http://dx.doi.org/10.1007/BF02937203

Vanhems P; Lambert J; Cooper DA; Perrin L; Carr AD; Hirscher B; Vizzard J; Kinloch-De Loes S; Allard R, 1998, 'Severity and prognosis of acute human immunodeficiency virus type 1 illness. A dose-response relationship', Clinical Infectious Diseases, vol. 26, pp. 323 - 329, http://dx.doi.org/10.1086/516289

Wang LL; Witherington C; King AD; Gerlach W; Carr AD; Penny R; Cooper DA; Symonds G; Sun L, 1998, 'Preclinical characterization of an anti-tat ribozyme for therapeutic application', Human Gene Therapy, vol. 9, pp. 1283 - 1291, http://dx.doi.org/10.1089/hum.1998.9.9-1283

Wurtz R; Carr A; Samaras K; Chisholm DJ; Cooper DA; Ho TTY; Chan KCW; Wong KH; Lee SS, 1998, 'Abnormal fat distribution and use of protease inhibitors (multiple letters) [7]', Lancet, vol. 351, pp. 1735 - 1736, http://dx.doi.org/10.1016/s0140-6736(05)77774-6

Carr A, 1997, 'Role of desensitisation for drug hypersensitivity in patients with HIV infection', Drug Safety, vol. 17, pp. 119 - 126, http://dx.doi.org/10.2165/00002018-199717020-00004

Carr AD; Brown DM; Cooper DA, 1997, 'Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor', AIDS, vol. 11, pp. 1657 - 1658

Carr AD; Cooper DA, 1997, 'CD8 T-cell response to antiretroviral therapy', Journal of acquired immune deficiency syndrome and human retrovirology, vol. 15, pp. 176 - 177, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XM57000016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Carr AD; Cooper DA, 1997, 'Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy', Lancet, vol. 350, pp. 589 - 589, http://dx.doi.org/10.1016/S0140-6736(05)63175-3

Carr AD; Cooper DA, 1997, 'Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor', Lancet, vol. 349, pp. 995 - 996, http://dx.doi.org/10.1016/S0140-6736(05)62892-9

De Jong MD; Vella S; Carr AD; Boucher CA; Imrie A; French MA; Hoy JF; Sorice S; Pauluzzi S; Chiodo F; Weverling GJ; Van Der Ende ME; Frissen PJ; Weigel HM; Kauffmann RH; Lange JM; Yoon R; Moroni M; Hoenderos E; Leitz G; Cooper DA; Hall D; Reiss P, 1997, 'High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication', Journal of Infectious Diseases, vol. 175, pp. 966 - 970, http://dx.doi.org/10.1086/514002

Imrie A; Beveridge A; Genn W; Vizzard J; Cooper DA; Catchpole BR; Baker D; Bloch M; Byrne J; Carr AD; Doong N; Duncombe CJ; Finlayson R; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1997, 'Transmission of human immunodeficiency virus type-1 resistant to nevirapine and zidovudine', Journal of Infectious Diseases, vol. 175, pp. 1502 - 1506, http://dx.doi.org/10.1086/516487

Kelleher S; Emery S; Cunningham PH; Duncombe CJ; Carr AD; Golding H; Forde S; Hudson J; Roggensack M; Forrest BD; Cooper DA, 1997, 'Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection', AIDS Research and Human Retroviruses, vol. 13, pp. 29 - 32, http://dx.doi.org/10.1089/aid.1997.13.29

Mitchell SM; Youle MS; Membrey WL; Jones CD; Uthayakumar S; Birthistle K; Dalton R; Hay PE; Stricker RB; Goldberg B; Carr A; Cooper DA; Stein DS; Jacobson MA, 1997, 'Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy (multiple letters) [10]', Lancet, vol. 350, pp. 588 - 590, http://dx.doi.org/10.1016/S0140-6736(97)26034-4

Stewart GA; Ashton LJ; Biti RA; Ffrench FA; Bennetts BH; Newcombe NR; Benson EM; Carr AD; Cooper DA; Kaldor JM; Smith DD; Catchpole BR; Allworth A; Baker D; Batty G; Beveridge A; Bloch M; Bodsworth NJ; Clare K; Cummins E; Cunningham PH; Couldwell D; Deacon N; Doong N; Finlayson R; Furner V; Huffam SE; Kidd J; Kelly MD; Lloyd AR; Mcfarlane R; Mclean K; Mcnulty A; Mcphee D; Michelmore H; Mcmurchie M; Mutimer K; Peterson J; Price R; Quan J; Qurn J; Ree H; Robertson M; Roggensack M; Schroeder K; Spencer D; Sullivan JS; Ziegler JB, 1997, 'Increased frequency of CCR-5 delta32 heterozygotes among long-term nonprogressors with HIV infection.', AIDS, vol. 11, pp. 1833 - 1838, http://dx.doi.org/10.1097/00002030-199715000-00007

Stricker RB; Goldberg B; Carr A; Cooper DA, 1997, 'CD8 T-cell response to antiretroviral therapy [1] (multiple letters)', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 15, pp. 176 - 177, http://dx.doi.org/10.1097/00042560-199706010-00015

Vanhems P; Allard R; Cooper DA; Perrin L; Vizzard J; Hirschel B; Kinloch-De Loes S; Carr AD; Lambert J, 1997, 'Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?', Clinical Infectious Diseases, vol. 24, pp. 965 - 970, http://dx.doi.org/10.1093/clinids/24.5.965

Carr A; Boyle MJ, 1996, 'Managing HIV. Part 2: Phases of disease. 2.1 Primary HIV infection.', Med J Aust, vol. 164, pp. 105 - 106, https://www.ncbi.nlm.nih.gov/pubmed/8569558

Carr A; Boyle MJ, 1996, 'Managing HIV: 2.1 Primary HIV infection', Medical Journal of Australia, vol. 164, pp. 105 - 106, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101365.x

Carr A; Boyle MJ, 1996, 'Primary HIV infection', MEDICAL JOURNAL OF AUSTRALIA, vol. 164, pp. 105 - 106, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101365.x

Carr A; Garsia R, 1996, 'How HIV leads to hypersensitivity reactions', Medical Journal of Australia, vol. 164, pp. 227 - 229, http://dx.doi.org/10.5694/j.1326-5377.1996.tb94146.x

Carr A; Garsia R, 1996, 'Managing HIV. Part 3: Mechanisms of disease. 3.5 How HIV leads to hypersensitivity reactions.', Med J Aust, vol. 164, pp. 227 - 229, https://www.ncbi.nlm.nih.gov/pubmed/8604194

Carr A; Roseingrave P; Fitzgerald MX, 1996, 'Factors associated with stress responses in staff caring for patients with cystic fibrosis', Irish Journal of Psychology, vol. 17, pp. 241 - 250, http://dx.doi.org/10.1080/3033910.1996.10558105

Carr AD; Cooper DA, 1996, 'Current clinical experience with nevirapine for HIV infection', Advances in Experimental Medicine and Biology, vol. 394, pp. 299 - 304

Carr AD; Cooper DA, 1996, 'HIV protease inhibitors', AIDS, vol. 10, pp. 151 - 157

Carr AD; Emery S; Kelleher AD; Law MG; Cooper DA, 1996, 'CD8+ lymphocyte responses to antiretroviral therapy of HIV infection', Journal of acquired immune deficiency syndrome and human retrovirology, vol. 13, pp. 320 - 326, http://dx.doi.org/10.1097/00042560-199612010-00004

Carr AD; Vella S; Dejong MD; Sorice F; Imrie A; Boucher CA; Cooper DA, 1996, 'A controller trial of nevirapine plus zidovudine versis zidovudine aklone in p24 antigenaemic HIV infected patients', AIDS, vol. 10, pp. 635 - 641

Cooper DA; Merigan TC, 1996, 'Clinical treatment.', AIDS (London, England), vol. 10 Suppl A, http://dx.doi.org/10.1097/00002030-199601001-00018

Coyle P; Carr AD; Depczynski BB; Chisholm DJ, 1996, 'Diabetes mellitus associated with pentamidine use in HIV-infected patients.', The Medical journal of Australia, vol. 165, pp. 587 - 588, http://dx.doi.org/10.5694/j.1326-5377.1996.tb138654.x

Imrie A; Carr A; Duncombe C; Finlayson R; Vizzard J; Law M; Kaldor J; Penny R; Cooper DA, 1996, 'Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group.', J Infect Dis, vol. 174, pp. 195 - 198, http://dx.doi.org/10.1093/infdis/174.1.195

Kelleher AD; Carr AD; Zaunders J; Cooper DA, 1996, 'Alterations in the immune response of HIV-infected subjects treated with an HIV specific protease inhibitor, ritonavir', Journal of Infectious Diseases, vol. 173, pp. 321 - 329, http://dx.doi.org/10.1093/infdis/173.2.321

Zhu T; Wang N; Carr AD; Nam DS; Moor-Jankowski R; Cooper DA; Ho DD, 1996, 'Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions:evidence for viral compartmentalisation and selection during sexual transmission', Journal of Virology, vol. 70, pp. 3098 - 3107

Carr A; Cooper DA, 1995, 'Pathogenesis and management of HIV-associated drug hypersensitivity.', AIDS clinical review, pp. 65 - 97

Danner SA; Carr A; Leonard JM; Lehman LM; Gudiol F; Gonzales J; Raventos A; Rubio R; Bouza E; Pintado V; Aguado AG; Delgado R; Borleffs JCC; Hsu A; Valdes JM; Boucher CAB; Cooper DA, 1995, 'Safety, pharmacokinetics, and antiviral activity of ritonavir, an inhibitor of HIV-1 protease', JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, vol. 10, pp. 75 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995UC13800076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Danner SA; Carr A; Leonard JM; Lehman LM; Gudiol F; Gonzales J; Raventos A; Rubio R; Bouza E; Pintado V; Aguado AG; Garcia de Lomas J; Delgado R; Borleffs JCC; Hsu A; Valdes JM; Boucher CAB; Cooper DA, 1995, 'A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of hiv-1 protease', New England Journal of Medicine, vol. 333, pp. 1528 - 1534, http://dx.doi.org/10.1056/NEJM199512073332303

Emery S; Carr A; Cooper DA, 1995, 'If it's the virus, why aren't we measuring it?', The Medical journal of Australia, vol. 163, pp. 508 - 509, http://dx.doi.org/10.5694/j.1326-5377.1995.tb124712.x

Kinloch-De Loes S; Hirschel B; Hoen B; Cooper DA; Tindall B; Carr AD; Saurat JH; Clumeck N; Lazzarin A; Mathiesen L; Raffi F; Antunes F; Von Overbeck J; Luthy R; Glauser M; Hawkins D; Baumberger C; Yerly S; Perneger TV; Perrin L, 1995, 'A controlled trial of zidovudine in primary human immunodeficiency virus infection', New England Journal of Medicine, vol. 333, pp. 408 - 413, http://dx.doi.org/10.1056/NEJM199508173330702

ZHU TF; WANG N; NAM DS; CAO YZ; CARR A; COOPER D; HO DD, 1995, 'PREFERENTIAL TRANSMISSION OF CELL-ASSOCIATED VIRUS AND EVIDENCE FOR SELECTION OF HIV-1 IN THE NEW HOST FOLLOWING SEXUAL CONTACT', JOURNAL OF CELLULAR BIOCHEMISTRY, pp. 230 - 230, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QT86500787&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zaunders J; Carr AD; Mcnally L; Penny R; Cooper DA, 1995, 'Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes', AIDS, vol. 9, pp. 561 - 566, http://dx.doi.org/10.1097/00002030-199506000-00005

Zhu T; Wang N; Carr A; Wolinsky S; Ho DD, 1995, 'Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor', Journal of Virology, vol. 69, pp. 1324 - 1327, http://dx.doi.org/10.1128/jvi.69.2.1324-1327.1995

Carr A; Cooper DA, 1994, 'In HIV‐infected individuals who desire combination antiviral therapy, zidovudine plus zalcitabine is preferred to zidovudine plus didanosine', Reviews in Medical Virology, vol. 4, pp. 5 - 8, http://dx.doi.org/10.1002/rmv.1980040104

Carr A; Gross AS; Hoskins JM; Penny R; Cooper DA, 1994, 'Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients', AIDS, vol. 8, pp. 333 - 337, http://dx.doi.org/10.1097/00002030-199403000-00006

Carr A; Vasak E; Munro V; Penny R; Cooper DA, 1994, 'Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection', Clinical and Experimental Immunology, vol. 97, pp. 260 - 265, http://dx.doi.org/10.1111/j.1365-2249.1994.tb06078.x

Carr A; Loewenthal M; Cooper DA, 1993, 'Update on reverse transcriptase inhibitors in HIV disease', Israel Journal of Medical Sciences, vol. 29, pp. 26 - 30

Carr A; Penny R; Cooper DA, 1993, 'Allergy and desensitization to zidovudine in patients with acquired immunodeficency syndrome (AIDS)', The Journal of Allergy and Clinical Immunology, vol. 91, pp. 683 - 685, http://dx.doi.org/10.1016/0091-6749(93)90276-L

Carr A; Penny R; Cooper DA, 1993, 'Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients', AIDS, vol. 7, pp. 65 - 71, http://dx.doi.org/10.1097/00002030-199301000-00010

Carr A; Penny R; Cooper DA, 1993, 'Prophylaxis of opportunistic infections in patients with HIV infection', Journal of Acquired Immune Deficiency Syndromes, vol. 6, pp. S56 - S60

Carr A; Swanson C; Penny R; Cooper DA, 1993, 'Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with pneumocystis carinii pneumonia and AIDS', Journal of Infectious Diseases, vol. 167, pp. 180 - 185, http://dx.doi.org/10.1093/infdis/167.1.180

Carr A; Tindall B; Penny R; Cooper DA, 1993, 'In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV', Clinical and Experimental Immunology, vol. 94, pp. 21 - 25, http://dx.doi.org/10.1111/j.1365-2249.1993.tb05971.x

Carr A; Tindall B; Penny R; Cooper DA, 1993, 'Patterns of multiple-drug hypersensitivities in HIV-infected patients [4]', AIDS, vol. 7, pp. 1532 - 1533, http://dx.doi.org/10.1097/00002030-199311000-00023

Caumes E; Lheriteau F; Gentilini M; Carr A; Tindall B; Cooper DA, 1993, 'Cotrimoxazole prophylaxis for toxoplasmosis [3]', Annals of Internal Medicine, vol. 118, pp. 395, http://dx.doi.org/10.7326/0003-4819-118-5-199303010-00018

Tindall B; Carr A; Goldstein D; Penny R; Cooper DA, 1993, 'Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response [1]', AIDS, vol. 7, pp. 127 - 128, http://dx.doi.org/10.1097/00002030-199301000-00020

Tindall B; Elford J; Sharkey T; Carr A; Kaldor J; Cooper DA, 1993, 'CD4+ lymphocytopenia in HIV-seronegative homosexual men [4]', AIDS, vol. 7, pp. 1272 - 1273

Tindall B; Forde S; Carr A; Barker S; Cooper DA, 1993, 'Attitudes to euthanasia and assisted suicide in a group of homosexual men with advanced HIV disease', Journal of Acquired Immune Deficiency Syndromes, vol. 6, pp. 1069 - 1070

Virus I; Masur H; Feinberg J; Bozzette SA; De Gruttola V; Edlin B; Eisinger R; El-Sadr W; Ellenberg S; Feigal D; Frame P; Goldberger M; Hafner R; Hardy WD; Harrington M; Hughes W; Kerkering T; Kovacs J; Leoung G; Montaner J; Muñoz A; Phair J; Sattler F; Spector S; Allen JR; Carr A; Chaisson R; Freedberg K; McKay J; Polis M, 1993, 'Recommendations for prophylaxis against pneumocystis carinii pneumonia for persons infected with human', Journal of Acquired Immune Deficiency Syndromes, vol. 6, pp. 46 - 55

Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA, 1992, 'Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS', Annals of Internal Medicine, vol. 117, pp. 106 - 111, http://dx.doi.org/10.7326/0003-4819-117-2-106

Carr A; Tindall B; Penny R; Cooper DA, 1992, 'Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS', AIDS, vol. 6, pp. 165 - 171, http://dx.doi.org/10.1097/00002030-199202000-00004

Carr A; Cooper DA; Penny R, 1991, 'Allergic manifestations of human immunodeficiency virus (HIV) infection', Journal of Clinical Immunology, vol. 11, pp. 55 - 64, http://dx.doi.org/10.1007/BF00917741

Carr A, 1990, 'Drug hypersensitivity', Medical Journal of Australia, vol. 153, pp. 631, http://dx.doi.org/10.5694/j.1326-5377.1990.tb126299.x

Ezard N; Clifford B; Dunlop A; Bruno R; Carr A; Liu Z; Siefried K; Lintzeris N, 2020, Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study, http://dx.doi.org/10.21203/rs.3.rs-30957/v1

Calon M; Menon K; Juge L; Carr A; Henry R; Rae C; Brew B; Cysique L, 2019, 'Cardiovascular Disease Risk Factors and HIV Disease Markers Increase Dementia Risk and Alter White Matter Microstructure in Virally Suppressed HIV Infected Men', in JOURNAL OF NEUROVIROLOGY, SPRINGER, GA, Atlanta, Vol. 25, pp. S6 - S7, presented at 16th International Symposium on NeuroVirology, GA, Atlanta, 12 November 2019 - 16 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000495782800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carr M; Martin SJ; Foster R; Finlayson R; Rule J; Smith DE; de Wit J; Carr A; Siefried KJ, 2019, 'STI incidence and risk factors in HIV-infected adults on antiretrovrial therapy (ART) in the PAART study', Perth, Australia, presented at Joint Australasian Sexual Health and HIV&AIDS Conference, Perth, Australia, 16 September 2019 - 19 September 2019

Ezard N; Dunlop AJ; Clifford B; Bruno R; Siefried KJ; Carr A; Lintzeris N, 2019, 'Safety of oral lisdexamfetamine in adults with methamphetamine dependence: a dose-escalating phase-2 study', San Antonio, Texas, USA, presented at The College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, Texas, USA, 15 June 2019 - 19 July 2019

Templeton DJ; Poynten IM; Jin F; Roberts JM; Law CLH; Cornall AM; Molano M; Machalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2019, 'The natural history of anal high grade squamous intraepithelial lesions in HIV positive and HIV negative gay and bisexual men', in HIV MEDICINE, WILEY, Vol. 20, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494690300029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vaccher S; Holt M; Prestage G; Amin J; Selvey C; Zablotska-Manos I; Guy R; Jin F; Carr A; Grulich A; Bavinton B, 2019, 'Methamphetamine users in the EPIC-NSW study report high adherence to pre-exposure prophylaxis (PrEP)', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/965b72bcb63f490083f4c0b91255431c

Siefried KJ, 2018, Antiretroviral therapy and treatment cascade outcomes in a cohort of adults living with HIV in Australia

Siefried KJ; Mao L; Riches S; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2018, 'Failure of antiretroviral therapy (ART) in adults in Australia is mainly due to ART toxicity (updated report with predictors of ART failure)', Amsterdam, the Netherlands, presented at 22nd International AIDS Conference, Amsterdam, the Netherlands, 23 July 2018 - 27 July 2018

Siefried KJ; Mao L; Riches S; Kerr S; Rule J; de Wit J; Carr A, 2018, 'Failure of antiretroviral therapy (ART) in adults in Australia is mainly due to ART toxicity (an updated report with predictors of ART failure)', Sydney, Australia, presented at The Australasian HIV&AIDS Conference, Sydney, Australia, 24 September 2018 - 26 September 2018

Siefried KJ; Mao L; Rule J; de Wit J; Carr A, 2018, 'Hospitalisations over a year follow-up in a cohort of adults living with HIV with sustained viral suppression in Australia', presented at The Australasian HIV&AIDS Conference, Sydney, Australia, 24 September 2018 - 26 September 2018

Siefried KJ; Mao L; Rule J; de Wit J; Carr A, 2018, 'Hospitalisations over a year follow-up in a cohort of adults living with HIV with sustained viral suppression in Australia', Amsterdam, the Netherlands, presented at 22nd International AIDS Conference, Amsterdam, the Netherlands, 23 July 2018 - 27 July 2018

Bruno R; Ezard N; Dunlop AJ; Clifford B; Carr A; Lintzeris N, 2017, 'COGNITIVE EFFECTS OF ESCALATING DOSES OF ORAL LISDEXAMFETAMINE IN METHAMPHETAMINE DEPENDENT ADULTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; de Wit J; Carr A, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017

Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; de Wit J; Carr A, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017

Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; de wit J; Carr A, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', presented at The Australasian HIV&AIDS Conference, Canberra Australia, 06 November 2017 - 08 November 2017

Siefried KJ; Mao L; Richardson R; Kerr S; Rule J; McAllister J; Carr A, 2017, 'Socioeconomic and psychosocial factors are associated with suboptimal outcomes in HIV-infected adults: a case-control analysis', Canberra, Australia, presented at The Australasian HIV&AIDS Conference, Canberra, Australia, 06 November 2017 - 08 November 2017

Siefried KJ; Mao L; Richardson R; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Socioeconomic and psychosocial factors are associated with suboptimal outcomes in HIV-infected adults: a case-control analysis', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017

Siefried KJ; Mao L; Richardson R; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Socioeconomic and psychosocial factors are associated with suboptimal outcomes in HIV-infected adults: a case-control analysis', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017

Siefried KJ; Mao L; Riches R; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017

Siefried KJ; Mao L; Riches S; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity', presented at The Australasian HIV&AIDS Conference, Canberra, Australia, 06 November 2017 - 08 November 2017

Siefried KJ; Mao L; Riches S; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017

Vaccher S; Marzinke M; Grulich AE; Ooi C; Carr A; Haire BG; Selvey C; Templeton DJ; Holt M; Crooks L; Zablotska I, 2017, 'High adherence to HIV pre-exposure prophylaxis (PrEP) in participants presenting for month 12 visit in PRELUDEopen-label study in NSW, Australia', Paris, France, presented at International AIDS Society, Paris, France, 23 July 2017 - 26 July 2017, http://programme.ias2017.org/Abstract/Abstract/3358

Chen W; Carr A; Center J; Pocock N, 2016, 'EFFECT OF SWITCH FROM TENOFOVIR TO RALTEGRAVIR ON TRABECULAR BONE SCORE', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, SINGAPORE, Singapore, Vol. 27, pp. S725 - S725, presented at IOF-Regionals 6th Asia-Pacific Osteoporosis Meeting, SINGAPORE, Singapore, 04 November 2016 - 06 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000388955600072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ezard N; Dunlop AJ; Carr A; McKetin R; Ali R; White J; Bruno R; Dolan K; Clifford B; Lintzeris N, 2016, 'A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE: THE LIMA STUDY PROTOCOL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 35 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Siefried KJ; Mao L; Kerr S; Gates T; Maynard A; Cysique LA; McAllister J; de Wit J; Carr A, 2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART study', in Antiviral Therapy, International Medical Press, New York City, USA, presented at The 18th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, New York City, USA, 12 September 2016 - 13 September 2016

Siefried KJ; Mao L; Kerr S; Gates T; Maynard A; Cysique LA; McAllister J; de Wit J; Carr A, 2016, 'Concomitant medication use in ART-experienced adults: data from the PAART study', presented at The Australasian HIV&AIDS Conference, Adelaide, Australia, 16 November 2016 - 18 November 2016

Siefried KJ; Mao L; Kerr S; Gates TM; Maynard A; Cysique LA; McAllister J; de Wit J; Carr A, 2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, NY, New York, Vol. 21, pp. A50 - A50, presented at 18th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV, NY, New York, 12 September 2016 - 13 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000389747500044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman R; Grulich A; Kelleher A; Carr A, 2016, 'T-cells in the anal mucosa of men with high- grade squamous intraepithelial lesions', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 240 - 240, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400486&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sasson SC; McGill K; Weinholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'COMPARISON OF THE FREELITE (TM) SERUM FREE LIGHT CHAIN (SFLC) ASSAY WITH SERUM AND URINE ELECTROPHORESIS/IMMUNOFIXATION AND THE N LATEX FLC ASSAY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360834700077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Siefried KJ; Mao L; Kerr S; Gates T; Cysique LA; de Wit J; Carr A, 2015, 'Parameters associated with adherence to antiretroviral therapy in HIV-infected Australian adults: the PAART study', presented at The Australasian HIV&AIDS Conference, Brisbane, Australia, 16 September 2015 - 18 September 2015

Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'T-CELLS IN THE ANAL MUCOSA OF MEN WITH HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 91, pp. A168 - A168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000416106400440&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vaccher S; Prestage G; McNulty A; Carr A; Holden J; Schmidt H-M; Holt M; Ooi C; Templeton D; Poynten M; Grulich A; Zablotska-Manos I, 2015, 'Characteristics of Gay Men in Sydney using HIV Pre-Exposure Prophylaxis (PrEP): Baseline Data from the PrELUDE Study', Brisbane, Australia, presented at Australian HIV and AIDS Conference, Brisbane, Australia, 16 September 2015

Siefried KJ; McAllister J; McNulty A; Read TR; Pearce A; Richardson R; Carr A, 2014, 'Safety and tolerability of, and adherence to, co-formulated emtricitabine-rilpivirine-tenofovir used as HIV non-occupational post-exposure prophylaxis in men who have sex with men', Sydney, Australia, presented at The St Vincent’s and Mater Health Research Symposium, Sydney, Australia, 11 September 2014 - 11 September 2014

Tong WWY; Bloch M; Hoy J; Baker D; Richardson R; Carr A, 2014, 'Changes in bone mineral density and markers of bone turnover over 96 weeks after switching from tenofovir to raltegravir', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A35 - A35, presented at 16th International Workshop on Co-Morbidities and Adverse Drug Reaction in HIV, PA, Philadelphia, 06 October 2014 - 08 October 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354600300036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Siefried KJ; Mao L; McAllister J; Richardson R; Watson J; de Wit J; Carr A, 2013, 'Predictors of adherence to antiretroviral therapy in HIV-infected adults (the PAART pilot study)', Darwin, Australia, presented at The Australasian HIV&AIDS Conference, Darwin, Australia, 21 October 2013 - 23 October 2013

Peacock A; Bruno R; Martin F; Carr A, 2012, 'PERCEPTION OF INTOXICATION FOLLOWING ALCOHOL AND ENERGY DRINK CONSUMPTION', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 31, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ebeling PR; Haskelberg H; Hoy J; Amin J; Emery S; Carr A, 2011, 'LOWER FAT MASS AND LOWER BONE FORMATION PREDICT GREATER BONE LOSS WITH TENOFOVIR IN HIV-INFECTED ADULTS', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, AUSTRALIA, Gold Coast, pp. S614 - S615, presented at IOF Regionals 2nd Asia-Pacific Osteoporosis and Bone Meeting / ANZBMS Annual Scientific Meeting held with the JSBMR, AUSTRALIA, Gold Coast, 04 September 2011 - 08 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309258200234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bloch M; Martin A; Amin I; Emery S; Carr A; Baker D; Cooper DA, 2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431500008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bloch M; Martin A; Amin J; Emery S; Carr A; Baker D; Cooper DA, 2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431200022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cysique LA; Myung-Lee J; Lane T; Moffat K; Davies N; Carr A; Brew BJ; Rae C, 2010, 'Glutamate excitotoxicity, cortical and subcortical neuronal damage as potential markers of HIV-associated neurocognitive disorder (HAND): A 1H-MRS and neuropsychological study', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, ITALY, Milan, pp. 22 - 23, presented at 10th International Symposium on NeuroVirology, ITALY, Milan, 12 October 2010 - 16 October 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283409800048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Puls RL; Brown D; Fahey P; Amin J; Breit S; Carr A, 2010, 'Macrophage inhibitory cytokine 1 (MIC-1) serum levels in the Lipodystrophy Case Definition Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A28 - A29, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431200046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Puls RL; Brown D; Fahey P; Amin J; Breit S; Carr A, 2010, 'Macrophage inhibitory cytokine 1 (MIC-1) serum levels in the Lipodystrophy Case Definition Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A28 - A29, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431500032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Distler O; Mallon PW; Kelleher AD; Carr A; Calmy A; Cooper DA, 2009, 'Evaluation of adipose gene expression and mitochondrial DNA in healthy adults over a 6 week course of NRTI and/or PI treatment. Indications of divergent effects', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A10 - A11, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272060000029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Currier JS; Lundgren JD; Carr A; Klein D; Sabin CA; Sax PE; Schouten JT; Smieja M, 2008, 'Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy', in Circulation, http://dx.doi.org/10.1161/CIRCULATIONAHA.107.189624

Grund B; Peng G; Isaksson R; Ellis K; Gilbert C; Shlay J; Drummond F; Martinez E; Hoy JF; Reiss P; El-Sadr W; Thomas A; Visnegarwala F; Carr AD, 2008, 'Continuous antiretroviral therapy decreases bone mineral density: results from the SMART study', in Antiviral Therapy, Int Medical Press Ltd, London, England, pp. A26 - A26, presented at Antiviral Therapy, London, ENGLAND, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000262341200039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A, 2006, 'Metabolic syndrome in HIV-infected patients using IDF and ATPIII criteria: prevalence, discordance and clinical utility', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CA, San Francisco, 24 September 2006 - 26 September 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241975800023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wand H; Calmy A; Carey D; Samaras K; Carr A; Law M; Cooper D; Emery S, 2006, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CA, San Francisco, 24 September 2006 - 26 September 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241975800024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carr A, 2004, 'HIV drug adverse events: Selected highlights from the 15th International AIDS Conference', in HIV Clinical Trials, pp. 252 - 256, http://dx.doi.org/10.1310/43UQ-4UTE-4RDE-B5UY

Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'HIV Lipodystrophy Case Definition Study Group. Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. 57 - 57

Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, Paris, FRANCE, pp. L73 - L73, presented at 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Paris, FRANCE, 08 July 2003 - 11 July 2003, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231266500130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Amin J; Carr A; Hill A; Emery S; Law M; Cooper DA, 2002, 'Haematological changes in patients randomized to HAART regimens containing either zidovudine or stavudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L60 - L60, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179501500101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mallon PWG; Munier ML; McGhie K; Zaunders J; Kelleher A; Cooper DA; Carr A, 2002, 'Disrupted expression of lipid transport genes in monocytes of individuals with HIV-associated lipodystrophy - an additional risk for cardiovascular disease?', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L8 - L9, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179501500023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Puls RL; Law M; Freund J; Gallagher D; Punyanitya M; Kalnins S; Carr A, 2002, 'The effect of centralized body composition data analysis on an objective case definition of HIV lipodystrophy', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L53 - L53, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179501500089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Imrie A; Carr AD; Duncombe CJ; Finlayson R; Vizzard J; Law MG; Kaldor JM; Penny R; Cooper DA, 1994, 'Primary infection with Zidovudine-resistant human immunodeficiency virus type 1 does not adverseley affect outcome at 1 year', in Journal of Infectious Diseases, University of Chicago Press, Chicago, IL, pp. 195 - 198, presented at International Workshop on HIV drug resistance, Hawaii, http://dx.doi.org/10.1093/infdis/174.1.195

Carr A; Penny R, 1993, 'Roundtable discussion: Management issues in didanosine therapy', in Journal of Acquired Immune Deficiency Syndromes, pp. S51 - S55